Diane Havlir, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Avenue, #4804
San Francisco CA
ORCID ORCID Icon0000-0003-0761-3136 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Case Western Reserve University, Cleveland, OHFellow1990Fellowship, Infectious Diseases
    University of California, San Francisco, San Francisco, CAResidency 1987Internal Medicine Residency
    Duke University Medical School, Durham, NCM.D.1984Medicine
    St. Olaf College, Northfield, MinnesotaB.A.1980Chemistry/Biology
    Collapse Awards and Honors
    National Academy of Medicine2019Elected Member
    National Institutes of Health, Washington DC2019James Hill Memorial Lecture, "Ending AIDS: The Wild West"
    Duke University Medical School2017Duke Distinguished Alumni Award
    Columbia University College of Physicians and Surgeons2016Visiting Professor
    San Francisco General Hospital Foundation2015Heroes and Hearts Award
    Project Inform2014Thomas M Kelley Leadership Award
    University of California, San Francisco2014Chancellors Award for the Advancement of Women
    University of California, San Francisco2014Pathways Mentorship Award
    St. Olaf College2013Alumni Achievement Award
    Infectious Diseases Society of America2012Joseph E. Smadel Infectious Diseases Society of America Award
    International AIDS Conference2012United States Co-Chair for XIX International AIDS Conference
    Vanity Fair2012Vanity Fair Hall of Fame, “Pioneering leader in the fight against AIDS”
    University of California, San Francisco2010AIDS Research Institute Award for Outstanding Mentoring
    International AIDS Conference2010Scientific Chair for XVIII International AIDS Conference, Vienna
    University of California, San Francisco2009Pediatric Mentorship Award
    State of California 2021Woman of the Year, District 19, California
    Zuckerberg San Francisco General Hospital 2021Elliot Rapaport Award
    Commonwealth Club, San Francisco 2021Distinguished Citizens Award
    University of California, San Francisco 2022Holly Smith Award
    University of California, San Francisco 2024UCSF Chancellor Award for Public Service
    Vanity Fair 2012Vanity Fair Hall of Fame

    Collapse Overview 
    Collapse Overview
    Diane Havlir, MD is a UCSF Professor and Chief of the HIV, Infectious Diseases and Global Medicine Division at ZSFG, home to world-renowned HIV research and Ward 86 clinical program. She is also the Associate Chair of Clinical Research in the Department of Medicine, Principal Investigator of the Sustainable East Africa Research in Community Health (SEARCH) Collaboration, Director of the UCSF AIDS Research Institute (ARI), and serves as Robert L. Weiss Memorial Chair for HIV/AIDS Research. She was elected to the National Academy of Medicine in 2019.

    Dr. Havlir was a resident at UCSF when the AIDS epidemic emerged in the 1980s, and has cared for HIV patients and conducted research—transforming national and international guidelines ever since. She is a long-standing NIH-funded investigator with over 400 publications including in the New England Journal of Medicine, JAMA, and other high impact journals. Dr. Havlir was a Co-founder and continues as Co-chair of San Francisco Getting to Zero (GTZ), a citywide consortium with a goal to eliminate new HIV infections and deaths. Dr. Havlir has been very active globally via leadership roles in the World Health Organization (WHO), having chaired the HIV global drug resistance surveillance network, and the HIV-TB working group. She co-chaired the WHO HIV treatment and prevention global guidelines, and Chaired the United Nations AIDS Scientific and Technical Advisory Committee, which provides high-level guidance on global action to combat the HIV/AIDS pandemic.

    The overall goal of her research is to develop therapeutic and prevention strategies to respond to global infectious disease pandemics: HIV, TB, and COVID-19. Antiretroviral therapy—for prevention or treatment—is one of the greatest successes in medicine, yet we have not fully used it to eliminate HIV or its complications such as tuberculosis (TB). In the first SEARCH study, Dr. Havlir and her team showed that a multi-disease, patient-centered approach to HIV testing and treatment reduced HIV incidence, HIV-associated tuberculosis and HIV-associated mortality, while improving population-level control of hypertension in a NIH-funded 320,000-person cluster-randomized study in rural East Africa. She continues towards her goal to accelerate the end of AIDS through the SEARCH-Sapphire study, which is testing an innovative “Community Precision Health” strategy which uses a multi-disease approach to incorporate AI and machine learning into delivery systems on a path to universal healthcare.

    During the COVID-19 pandemic, Dr. Havlir established the city-community-academic partnership Unidos en Salud, which provided low barrier test-and-respond and vaccine services to thousands of persons and tracked epidemiologic trends in the Mission district of San Francisco. This collaboration with the Latino Task Force, CZ Biohub, SFDPH and BayPLS is now studying molecular epidemiology of circulating respiratory viruses and prototyping new approaches to provide vaccine, testing and treatment services to the disproportionately affected Latinx population.
    Collapse In The News
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
    NIH U01AI150510Sep 25, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Strategic antiretroviral therapy and HIV testing for youth in rural Africa
    NIH UH3HD096915Sep 1, 2018 - Aug 31, 2023
    Role: Principal Investigator
    Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)
    NIH/NICHD UH3HD96915Sep 1, 2018 - Aug 31, 2023
    Role: Principal Investigator
    Description: This study will bridge significant scientific knowledge gaps in our understanding of effective ways to improve knowledge of HIV status and HIV care and virologic suppression (the main success measure of treatment) among adolescents and young adults.
    Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
    NIH R01AI125000Dec 14, 2016 - Nov 30, 2022
    Role: Principal Investigator
    San Francisco Bay Clinical Trial Units
    NIH/NIAID UM1AI069496Jan 10, 2013 - Nov 30, 2027
    Role: Co-Investigator
    Description: This cooperative agreement supports studies of HIV and its complications. These studies are designed by ACTG HIV researchers and conducted through a network of domestic and international sites.
    Training in HIV Translational Research
    NIH T32AI060530Jul 1, 2004 - Jul 31, 2026
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Illness Narratives Without the Illness: Biomedical HIV Prevention Narratives from East Africa. J Med Humanit. 2024 Jun 26. Johnson-Peretz J, Atwine F, Kamya MR, Ayieko J, Petersen ML, Havlir DV, Camlin CS. PMID: 38918249.
      View in: PubMed   Mentions:    Fields:    
    2. Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda. Clin Infect Dis. 2024 Jun 02. Abbott R, Landsiedel K, Atukunda M, Puryear SB, Chamie G, Hahn JA, Mwangwa F, Kakande E, Petersen ML, Havlir DV, Charlebois E, Balzer LB, Kamya MR, Marquez C. PMID: 38824440.
      View in: PubMed   Mentions:    Fields:    
    3. The effect of an intervention to promote isoniazid preventive therapy on leadership and management abilities. Public Health Action. 2024 Jun; 14(2):56-60. Christian C, Kakande E, Nahurira V, Balzer LB, Owaraganise A, Nugent JR, DiIeso W, Rast D, Kabami J, Peretz JJ, Camlin CS, Shade SB, Kamya MR, Havlir DV, Chamie G. PMID: 38957498; PMCID: PMC11216294.
      View in: PubMed   Mentions:
    4. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa. Lancet. 2024 May 25; 403(10441):2291-2292. Havlir D, Kamya MR, Petersen M. PMID: 38796205.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Exploring HIV risk perception mechanisms among youth in a test-and-treat trial in Kenya and Uganda. PLOS Glob Public Health. 2024; 4(5):e0002922. Owino L, Johnson-Peretz J, Lee J, Getahun M, Coppock-Pector D, Maeri I, Onyango A, Cohen CR, Bukusi EA, Kabami J, Ayieko J, Petersen M, Kamya MR, Charlebois E, Havlir D, Camlin CS. PMID: 38696376; PMCID: PMC11065277.
      View in: PubMed   Mentions:
    6. Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease. medRxiv. 2024 Mar 28. Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso M, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA. PMID: 38585951; PMCID: PMC10996734.
      View in: PubMed   Mentions:
    7. Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed. J Acquir Immune Defic Syndr. 2024 Mar 27. Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, Szumowski JD, Appa A, Koester K, Dauria EF, McNulty M, Colasanti J, Havlir DV, Gandhi M, Christopoulos KA. PMID: 38534179.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya. J Acquir Immune Defic Syndr. 2024 Apr 15; 95(5):447-455. Kabami J, Koss CA, Sunday H, Biira E, Nyabuti M, Balzer LB, Gupta S, Chamie G, Ayieko J, Kakande E, Bacon MC, Havlir D, Kamya MR, Petersen M, SEARCH Study Team. PMID: 38489493; PMCID: PMC10927304.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    9. Mid-level managers' perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study. BMC Health Serv Res. 2024 Mar 08; 24(1):313. Christian C, Kakande E, Nahurira V, Akatukwasa C, Atwine F, Bakanoma R, Itiakorit H, Owaraganise A, DiIeso W, Rast D, Kabami J, Peretz JJ, Shade SB, Kamya MR, Havlir DV, Chamie G, Camlin CS. PMID: 38454501; PMCID: PMC10921742.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    10. My Personal Calling. Clin Infect Dis. 2024 02 17; 78(2):238-239. Havlir DV. PMID: 37791969.
      View in: PubMed   Mentions:    Fields:    
    11. Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial. Clin Infect Dis. 2024 Jan 16. Marquez C, Atukunda M, Nugent J, Charlebois ED, Chamie G, Mwangwa F, Ssemmondo E, Kironde J, Kabami J, Owaraganise A, Kakande E, Ssekaynzi B, Abbott R, Ayieko J, Ruel T, Kwariisima D, Kamya M, Petersen M, Havlir DV, Balzer LB. PMID: 38226445.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Lessons from Two Latino Communities Working with Academic Partners to Increase Access to COVID-19 Testing. Prog Community Health Partnersh. 2024; 18(1):e1-e2. Garibay KK, Durazo A, Vizcaíno T, Oviedo Y, Marson K, Arechiga C, Prado P, Carrera O, Alvarado MJ, Havlir DV, Rojas S, Chamie G, Marquez C, Sauceda J, Yen IH, De Trinidad Young ME. PMID: 38682405.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. Lessons from Two Latino Communities Working with Academic Partners to Increase Access to COVID-19 Testing. Prog Community Health Partnersh. 2024; 18(1):e1-e2. Garibay KK, Durazo A, Vizcaíno T, Oviedo Y, Marson K, Arechiga C, Prado P, Carrera O, Alvarado MJ, Havlir DV, Rojas S, Chamie G, Marquez C, Sauceda J, Yen IH, De Trinidad Young ME. PMID: 38661819.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. Lessons from Two Latino Communities Working with Academic Partners to Increase Access to COVID-19 Testing. Prog Community Health Partnersh. 2024; 18(1):1-9. Garibay KK, Durazo A, Vizcaíno T, Oviedo Y, Marson K, Arechiga C, Prado P, Carrera O, Alvarado MJ, Havlir DV, Rojas S, Chamie G, Marquez C, Sauceda J, Yen IH, De Trinidad Young ME. PMID: 38661822; PMCID: PMC11076150.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Clinical Implications of HIV Treatment and Prevention for Polygamous Families in Kenya and Uganda: "My Co-Wife Is the One Who Used to Encourage Me". J Int Assoc Provid AIDS Care. 2024 Jan-Dec; 23:23259582241255171. Johnson-Peretz J, Onyango A, Gutin SA, Balzer L, Akatukwasa C, Owino L, Arunga TMO, Atwine F, Petersen M, Kamya M, Ayieko J, Ruel T, Havlir D, Camlin CS. PMID: 38751360; PMCID: PMC11100383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial. Lancet Glob Health. 2023 Dec; 11(12):e1899-e1910. Chamie G, Hahn JA, Kekibiina A, Emenyonu NI, Beesiga B, Marson K, Fatch R, Lodi S, Adong J, Thirumurthy H, McDonell MG, Gandhi M, Bryant K, Havlir DV, Kamya MR, Muyindike WR. PMID: 37973340; PMCID: PMC11005200.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Randomized Trial of a "Dynamic Choice" Patient-Centered Care Intervention for Mobile Persons With HIV in East Africa. J Acquir Immune Defic Syndr. 2024 01 01; 95(1):74-81. Ayieko J, Balzer LB, Inviolata C, Kakande E, Opel F, Wafula EM, Kabami J, Owaraganise A, Mwangwa F, Nakato H, Bukusi EA, Camlin CS, Charlebois ED, Bacon MC, Petersen ML, Kamya MR, Havlir DV, Chamie G, SEARCH Study Team. PMID: 38054932; PMCID: PMC10695335.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial. J Int AIDS Soc. 2023 Dec; 26(12):e26195. Kakande ER, Ayieko J, Sunday H, Biira E, Nyabuti M, Agengo G, Kabami J, Aoko C, Atuhaire HN, Sang N, Owaranganise A, Litunya J, Mugoma EW, Chamie G, Peng J, Schrom J, Bacon MC, Kamya MR, Havlir DV, Petersen ML, Balzer LB, SEARCH Study Team. PMID: 38054535; PMCID: PMC10698808.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    19. Effect of a brief alcohol counselling intervention on HIV viral suppression and alcohol use among persons with HIV and unhealthy alcohol use in Uganda and Kenya: a randomized controlled trial. J Int AIDS Soc. 2023 Dec; 26(12):e26187. Puryear SB, Mwangwa F, Opel F, Chamie G, Balzer LB, Kabami J, Ayieko J, Owaraganise A, Kakande E, Agengo G, Bukusi E, Kabageni S, Omoding D, Bacon M, Schrom J, Woolf-King S, Petersen ML, Havlir DV, Kamya M, Hahn JA. PMID: 38054564; PMCID: PMC10698822.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Improving care engagement for mobile people living with HIV in rural western Kenya. PLoS One. 2023; 18(11):e0288087. Ayieko J, Charlebois ED, Maeri I, Owino L, Thorp M, Bukusi EA, Petersen ML, Kamya MR, Havlir DV, Camlin CS. PMID: 37992063; PMCID: PMC10664942.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Geographic Mobility and HIV Care Engagement among People Living with HIV in Rural Kenya and Uganda. Trop Med Infect Dis. 2023 Nov 10; 8(11). Ayieko J, Thorp M, Getahun M, Gandhi M, Maeri I, Gutin SA, Okiring J, Kamya MR, Bukusi EA, Charlebois ED, Petersen M, Havlir DV, Camlin CS, Murnane PM. PMID: 37999615; PMCID: PMC10675546.
      View in: PubMed   Mentions:
    22. Geographical, social, and political contexts of tuberculosis control and intervention, as reported by mid-level health managers in Uganda: 'The activity around town'. Soc Sci Med. 2023 12; 338:116363. Johnson-Peretz J, Chamie G, Kakande E, Christian C, Kamya MR, Akatukwasa C, Atwine F, Havlir DV, Camlin CS. PMID: 37944344; PMCID: PMC10878310.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda. AIDS. 2024 Mar 01; 38(3):339-349. Koss CA, Ayieko J, Kabami J, Balzer LB, Kakande E, Sunday H, Nyabuti M, Wafula E, Shade SB, Biira E, Opel F, Atuhaire HN, Okochi H, Ogachi S, Gandhi M, Bacon MC, Bukusi EA, Chamie G, Petersen ML, Kamya MR, Havlir DV, SEARCH study team. PMID: 37861683.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    24. Universal HIV Testing and Treatment With Patient-Centered Care Improves ART Uptake and Viral Suppression Among Adults Reporting Hazardous Alcohol Use in Uganda and Kenya. J Acquir Immune Defic Syndr. 2023 09 01; 94(1):37-45. Puryear SB, Ayieko J, Hahn JA, Mucunguzi A, Owaraganise A, Schwab J, Balzer LB, Kwarisiima D, Charlebois ED, Cohen CR, Bukusi EA, Petersen ML, Havlir DV, Kamya MR, Chamie G. PMID: 37220015; PMCID: PMC10524467.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. A multilevel health system intervention for virological suppression in adolescents and young adults living with HIV in rural Kenya and Uganda (SEARCH-Youth): a cluster randomised trial. Lancet HIV. 2023 08; 10(8):e518-e527. Ruel T, Mwangwa F, Balzer LB, Ayieko J, Nyabuti M, Mugoma WE, Kabami J, Kamugisha B, Black D, Nzarubara B, Opel F, Schrom J, Agengo G, Nakigudde J, Atuhaire HN, Schwab J, Peng J, Camlin C, Shade SB, Bukusi E, Kapogiannis BG, Charlebois E, Kamya MR, Havlir D. PMID: 37541706.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Population-level viremia predicts HIV incidence at the community level across the Universal Testing and Treatment Trials in eastern and southern Africa. PLOS Glob Public Health. 2023; 3(7):e0002157. Larmarange J, Bachanas P, Skalland T, Balzer LB, Iwuji C, Floyd S, Mills LA, Pillay D, Havlir D, Kamya MR, Ayles H, Wirth K, Dabis F, Hayes R, Petersen M, UT³C consortium. PMID: 37450436; PMCID: PMC10348573.
      View in: PubMed   Mentions: 1  
    27. San Francisco's Citywide COVID-19 Response: Strategies to Reduce COVID-19 Severity and Health Disparities, March 2020 Through May 2022. Public Health Rep. 2023 Sep-Oct; 138(5):747-755. Sachdev DD, Petersen M, Havlir DV, Schwab J, Enanoria WTA, Nguyen TQ, Mercer MP, Scheer S, Bennett A, Tenner AG, Marks JD, Bobba N, Philip S, Colfax G. PMID: 37408322; PMCID: PMC10323495.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    28. Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV. Ann Intern Med. 2023 07; 176(7):969-974. Gandhi M, Hickey M, Imbert E, Grochowski J, Mayorga-Munoz F, Szumowski JD, Oskarsson J, Shiels M, Sauceda J, Salazar J, Dilworth S, Nguyen JQ, Glidden DV, Havlir DV, Christopoulos KA. PMID: 37399555; PMCID: PMC10771861.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study. J Int AIDS Soc. 2023 07; 26 Suppl 1:e26121. Kabami J, Kakande E, Chamie G, Balzer LB, Petersen ML, Camlin CS, Nyabuti M, Koss CA, Bukusi EA, Kamya MR, Havlir DV, Ayieko J. PMID: 37408473; PMCID: PMC10323314.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    30. CROI 2023: Tuberculosis and Infectious Complications in Persons With HIV. Top Antivir Med. 2023 Jun 30; 31(4):529-537. Kerkhoff AD, Havlir DV. PMID: 37704200; PMCID: PMC10424761.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Weight Change Following Switch to Dolutegravir for HIV Treatment in Rural Kenya During Country Roll-Out. J Acquir Immune Defic Syndr. 2023 06 01; 93(2):154-161. Hickey MD, Wafula E, Ogachi SM, Ojwando H, Orori G, Adede RO, Garraza LG, Petersen ML, Havlir DV, Balzer LB, Ayieko J. PMID: 36787723; PMCID: PMC10293078.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials. Biostatistics. 2023 04 14; 24(2):502-517. Balzer LB, van der Laan M, Ayieko J, Kamya M, Chamie G, Schwab J, Havlir DV, Petersen ML. PMID: 34939083; PMCID: PMC10102904.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 Apr 06; 388(14):1296-1306. Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C, DoxyPEP Study Team. PMID: 37018493; PMCID: PMC10140182.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    34. Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges. PLoS One. 2023; 18(3):e0283576. Schrom J, Marquez C, Wang CY, Saxena A, Mitchell AM, Ribeiro S, Pilarowski G, Nakamura R, Rojas S, Black D, Contreras Oseguera MG, Diaz EC, Payan J, Rojas S, Jones D, Tulier-Laiwa V, Zavaleta A, Martinez J, Chamie G, Glaser C, Jacobson K, Petersen M, DeRisi J, Havlir DV. PMID: 36961855; PMCID: PMC10038282.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    35. HIV post-treatment controllers have distinct immunological and virological features. Proc Natl Acad Sci U S A. 2023 03 14; 120(11):e2218960120. Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP, Yuki Y, Martin MP, Carrington M, Gandhi RT, Jacobson JM, Volberding P, Connick E, Mitsuyasu R, Frank I, Saag M, Eron JJ, Skiest D, Margolis DM, Havlir D, Schooley RT, Lederman MM, Yu XG, Li JZ. PMID: 36877848; PMCID: PMC10089217.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    36. Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial. Clin Infect Dis. 2023 02 18; 76(4):600-608. Bangirana P, Conroy AL, Opoka RO, Semrud-Clikeman M, Jang JH, Apayi C, Kakuru A, Muhindo MK, Georgieff MK, Dorsey GM, Kamya MR, Havlir D, John CC. PMID: 36219705; PMCID: PMC10169410.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic. Clin Infect Dis. 2023 02 08; 76(3):e645-e651. Christopoulos KA, Grochowski J, Mayorga-Munoz F, Hickey MD, Imbert E, Szumowski JD, Dilworth S, Oskarsson J, Shiels M, Havlir D, Gandhi M. PMID: 35913500; PMCID: PMC9907477.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    38. The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in 9 Rural Ugandan Communities. Clin Infect Dis. 2023 02 08; 76(3):e902-e909. Marquez C, Chen Y, Atukunda M, Chamie G, Balzer LB, Kironde J, Ssemmondo E, Mwangwa F, Kabami J, Owaraganise A, Kakande E, Abbott R, Ssekyanzi B, Koss C, Kamya MR, Charlebois ED, Havlir DV, Petersen ML. PMID: 35982635; PMCID: PMC10169405.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    39. Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa. BMC Public Health. 2022 12 13; 22(1):2333. Sabapathy K, Balzer L, Larmarange J, Block L, Floyd S, Iwuji C, Wirth K, Ayles H, Fidler S, Kamya M, Petersen M, Havlir D, Dabis F, Moore J, Hayes R. PMID: 36514036; PMCID: PMC9746009.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    40. A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants. mSystems. 2023 02 23; 8(1):e0067122. Albright J, Mick E, Sanchez-Guerrero E, Kamm J, Mitchell A, Detweiler AM, Neff N, Tsitsiklis A, Hayakawa Serpa P, Ratnasiri K, Havlir D, Kistler A, DeRisi JL, Pisco AO, Langelier CR. PMID: 36507688; PMCID: PMC9948727.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    41. Feasibility and preliminary effectiveness of integrating HIV prevention into an adolescent empowerment and livelihood intervention at youth clubs in rural Uganda. AIDS Care. 2023 01; 35(1):41-47. Christian C, Kabami J, Kwarisiima D, Beinamatsiko B, Nakato H, Khakshi JW, Sulaiman M, Komugisha A, Thirumurthy H, Havlir DV, Kamya MR, Chamie G. PMID: 36473203; PMCID: PMC10006396.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    42. Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: A randomized controlled trial. PLoS One. 2022; 17(11):e0277312. Hickey MD, Owaraganise A, Sang N, Opel FJ, Mugoma EW, Ayieko J, Kabami J, Chamie G, Kakande E, Petersen ML, Balzer LB, Kamya MR, Havlir DV. PMID: 36342940; PMCID: PMC9639834.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Reproducibility and implementation of a rapid, community-based COVID-19 "test and respond" model in low-income, majority-Latino communities in Northern California. PLoS One. 2022; 17(10):e0276257. Chamie G, Prado P, Oviedo Y, Vizcaíno T, Arechiga C, Marson K, Carrera O, Alvarado MJ, Corchado CG, Gomez M, Mochel M, de Leon I, Garibay KK, Durazo A, Young MT, Yen IH, Sauceda J, Rojas S, DeRisi J, Petersen M, Havlir DV, Marquez C. PMID: 36301834; PMCID: PMC9612491.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing Homelessness. J Infect Dis. 2022 10 07; 226(Suppl 3):S353-S362. Hickey MD, Imbert E, Appa A, Del Rosario JB, Lynch E, Friend J, Avila R, Clemenzi-Allen A, Riley ED, Gandhi M, Havlir DV. PMID: 35759251; PMCID: PMC10233499.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda. AIDS Patient Care STDS. 2022 10; 36(10):396-404. Camlin CS, Getahun M, Koss CA, Owino L, Akatukwasa C, Itiakorit H, Onyango A, Bakanoma R, Atwine F, Maeri I, Ayieko J, Atukunda M, Owaraganise A, Mwangwa F, Sang N, Kabami J, Kaplan RL, Chamie G, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Charlebois ED. PMID: 36201226; PMCID: PMC9595612.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    46. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods. JAMA Netw Open. 2022 10 03; 5(10):e2235844. Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang CY, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-Laiwa V, Petersen M, DeRisi J, Havlir DV. PMID: 36215069; PMCID: PMC9552893.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    47. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge. Ann Intern Med. 2022 10; 175(10):W119. Schrom J, Marquez C, Petersen M, DeRisi J, Havlir D. PMID: 36252253.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    48. CROI 2022: tuberculosis and infectious complications in persons With HIV. Top Antivir Med. 2022 Oct-Nov; 30(3):528-536. Kerkhoff AD, Havlir DV. PMID: 36347059; PMCID: PMC9473896.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Same-day test and treat for infants with HIV infection: finally within reach. J Int AIDS Soc. 2022 09; 25(9):e26016. Vojnov L, Havlir D, Myer L, Abrams E, Jani I. PMID: 36134602; PMCID: PMC9494203.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    50. Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis. Clin Infect Dis. 2022 08 24; 75(1):e947-e954. Spinelli MA, Le Tourneau N, Glidden DV, Hsu L, Hickey MD, Imbert E, Arreguin M, Jain JP, Oskarsson JJ, Buchbinder SP, Johnson MO, Havlir D, Christopoulos KA, Gandhi M. PMID: 35245934; PMCID: PMC9129130.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    51. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics and Immune Responses in a Household of Vaccinated Persons. Clin Infect Dis. 2022 08 24; 75(1):e303-e306. Liu J, Laurie MT, Rubio L, Vazquez SE, Sunshine S, Mitchell AM, Hapte-Selassie M, Mann SA, Pilarowski G, Black D, Marquez C, Rojas S, Lionakis MS, Petersen M, Whitman JD, Jain V, Anderson M, Havlir D, DeRisi J. PMID: 35037050; PMCID: PMC8807302.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    52. Patient Preferences for Strategies to Improve Tuberculosis Diagnostic Services in Zambia. JAMA Netw Open. 2022 08 01; 5(8):e2229091. Kerkhoff AD, Chilukutu L, Nyangu S, Kagujje M, Mateyo K, Sanjase N, Eshun-Wilson I, Geng EH, Havlir DV, Muyoyeta M. PMID: 36036933; PMCID: PMC9425150.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa. Viruses. 2022 07 29; 14(8). Pujol-Hodge E, Salazar-Gonzalez JF, Ssemwanga D, Charlebois ED, Ayieko J, Grant HE, Liegler T, Atkins KE, Kaleebu P, Kamya MR, Petersen M, Havlir DV, Leigh Brown AJ. PMID: 36016295; PMCID: PMC9414799.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    54. A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial. Lancet HIV. 2022 09; 9(9):e607-e616. Kakande E, Christian C, Balzer LB, Owaraganise A, Nugent JR, DiIeso W, Rast D, Kabami J, Johnson Peretz J, Camlin CS, Shade SB, Geng EH, Kwarisiima D, Kamya MR, Havlir DV, Chamie G. PMID: 35908553; PMCID: PMC9536151.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    55. "I was still very young": agency, stigma and HIV care strategies at school, baseline results of a qualitative study among youth in rural Kenya and Uganda. J Int AIDS Soc. 2022 07; 25 Suppl 1:e25919. Johnson-Peretz J, Lebu S, Akatukwasa C, Getahun M, Ruel T, Lee J, Ayieko J, Mwangwa F, Owino L, Onyango A, Maeri I, Atwine F, Charlebois ED, Bukusi EA, Kamya MR, Havlir DV, Camlin CS. PMID: 35818888; PMCID: PMC9274360.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    56. Brief Report: Heterogeneous Preferences for Care Engagement Among People With HIV Experiencing Homelessness or Unstable Housing During the COVID-19 Pandemic. J Acquir Immune Defic Syndr. 2022 06 01; 90(2):140-145. Imbert E, Hickey MD, Del Rosario JB, Conte M, Kerkhoff AD, Clemenzi-Allen A, Riley ED, Havlir DV, Gandhi M. PMID: 35262529; PMCID: PMC9203876.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    57. SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron. J Infect Dis. 2022 06 01; 225(11):1909-1914. Laurie MT, Liu J, Sunshine S, Peng J, Black D, Mitchell AM, Mann SA, Pilarowski G, Zorn KC, Rubio L, Bravo S, Marquez C, Sabatino JJ, Mittl K, Petersen M, Havlir D, DeRisi J. PMID: 34979030; PMCID: PMC8755395.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    58. Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya. AIDS Care. 2023 01; 35(1):95-105. Mwangwa F, Charlebois ED, Ayieko J, Olio W, Black D, Peng J, Kwarisiima D, Kabami J, Balzer LB, Petersen ML, Kapogiannis B, Kamya MR, Havlir DV, Ruel TD. PMID: 35578398; PMCID: PMC9666617.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    59. Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program. JAMA Netw Open. 2022 05 02; 5(5):e2214163. Kerkhoff AD, Rojas S, Black D, Ribeiro S, Rojas S, Valencia R, Lemus J, Payan J, Schrom J, Jones D, Manganelli S, Bandi S, Chamie G, Tulier-Laiwa V, Petersen M, Havlir D, Marquez C. PMID: 35616939; PMCID: PMC9136625.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    60. PEP for HIV prevention: are we missing opportunities to reduce new infections? J Int AIDS Soc. 2022 05; 25(5):e25942. Ayieko J, Petersen ML, Kamya MR, Havlir DV. PMID: 35633097; PMCID: PMC9142817.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Lancet HIV. 2022 05; 9(5):e353-e362. Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V, HIV Modelling Consortium. PMID: 35489378; PMCID: PMC9065367.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    62. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant. Open Forum Infect Dis. 2022 May; 9(5):ofac135. Acharya CB, Schrom J, Mitchell AM, Coil DA, Marquez C, Rojas S, Wang CY, Liu J, Pilarowski G, Solis L, Georgian E, Belafsky S, Petersen M, DeRisi J, Michelmore R, Havlir D. PMID: 35479304; PMCID: PMC8992250.
      View in: PubMed   Mentions: 26  
    63. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A Cross-Sectional Study. Ann Intern Med. 2022 05; 175(5):682-690. Schrom J, Marquez C, Pilarowski G, Wang CY, Mitchell A, Puccinelli R, Black D, Rojas S, Ribeiro S, Tulier-Laiwa V, Martinez J, Payan J, Rojas S, Jones D, Martinez D, Nakamura R, Chamie G, Jain V, Petersen M, DeRisi J, Havlir D. PMID: 35286144; PMCID: PMC8943844.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    64. Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco. Clin Infect Dis. 2022 01 07; 74(1):32-39. Peng J, Liu J, Mann SA, Mitchell AM, Laurie MT, Sunshine S, Pilarowski G, Ayscue P, Kistler A, Vanaerschot M, Li LM, McGeever A, Chow ED, Marquez C, Nakamura R, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Naso J, Schwab J, Petersen M, Havlir D, DeRisi J, IDseq Team. PMID: 33788923; PMCID: PMC8083548.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    65. Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial. Lancet Glob Health. 2022 01; 10(1):e96-e104. Jakubowski A, Kabami J, Balzer LB, Ayieko J, Charlebois ED, Owaraganise A, Marquez C, Clark TD, Black D, Shade SB, Chamie G, Cohen CR, Bukusi EA, Kamya MR, Petersen M, Havlir DV, Thirumurthy H. PMID: 34919862.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    66. SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron. medRxiv. 2021 Dec 22. Laurie MT, Liu J, Sunshine S, Peng J, Black D, Mitchell AM, Mann SA, Pilarowski G, Zorn KC, Rubio L, Bravo S, Marquez C, Sabatino JJ, Mittl K, Petersen M, Havlir D, DeRisi J. PMID: 34981075; PMCID: PMC8722618.
      View in: PubMed   Mentions: 1  
    67. High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community. Health Equity. 2021; 5(1):840-846. Naso J, Rojas S, Peng J, Marquez C, Contreras M, Castellanos E, Rojas S, Rubio L, Jones D, Jacobo J, Black D, Tulier-Laiwa V, Martinez J, Chamie G, Pilarowski G, DeRisi J, Havlir D, Petersen M. PMID: 35018317; PMCID: PMC8742294.
      View in: PubMed   Mentions:
    68. SARS-CoV-2 vaccine boosters: The time to act is now. PLoS Med. 2021 12; 18(12):e1003882. Petersen M, Schwab J, Havlir DV. PMID: 34882675; PMCID: PMC8700008.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    69. Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):340-347. Le Guillou A, Buchbinder S, Scott H, Liu A, Havlir D, Scheer S, Jenness SM. PMID: 34354011; PMCID: PMC8556308.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    70. SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV. AIDS. 2021 12 01; 35(15):2545-2547. Spinelli MA, Brown LB, Glidden DV, Hunter K, Martin-Tuite P, Zheng J, Sera C, Havlir D, Buchbinder SP, Gandhi M. PMID: 34870933; PMCID: PMC8673488.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    71. Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing. Clin Infect Dis. 2021 11 02; 73(9):e3098-e3101. Pilarowski G, Marquez C, Rubio L, Peng J, Martinez J, Black D, Chamie G, Jones D, Jacobo J, Tulier-Laiwa V, Rojas S, Rojas S, Cox C, Nakamura R, Petersen M, DeRisi J, Havlir DV. PMID: 33367619; PMCID: PMC7799223.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCellsPHPublic Health
    72. Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco. Am J Prev Med. 2021 11; 61(5 Suppl 1):S47-S54. Bacon OML, Coffey SC, Hsu LC, Chin JCS, Havlir DV, Buchbinder SP. PMID: 34686290.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    73. Examining the Impact of the Golden Compass Clinical Care Program for Older People with HIV: A Qualitative Study. AIDS Behav. 2022 May; 26(5):1562-1571. Tan JY, Greene M, Blat C, Albers A, Grochowski J, Oskarsson J, Shiels M, Hsue P, Havlir D, Gandhi M, Myers J. PMID: 34705153; PMCID: PMC8548856.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    74. SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts. Clin Infect Dis. 2021 10 05; 73(7):e1938-e1945. Kamya MR, Petersen ML, Kabami J, Ayieko J, Kwariisima D, Sang N, Clark TD, Schwab J, Charlebois ED, Cohen CR, Bukusi EA, Peng J, Jain V, Chen YH, Chamie G, Balzer LB, Havlir DV. PMID: 33783495; PMCID: PMC8492199.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    75. A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice. PLoS One. 2021; 16(9):e0257111. Marquez C, Kerkhoff AD, Naso J, Contreras MG, Castellanos Diaz E, Rojas S, Peng J, Rubio L, Jones D, Jacobo J, Rojas S, Gonzalez R, Fuchs JD, Black D, Ribeiro S, Nossokoff J, Tulier-Laiwa V, Martinez J, Chamie G, Pilarowski G, DeRisi J, Petersen M, Havlir DV. PMID: 34543291; PMCID: PMC8452046.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    76. Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda. PLoS Med. 2021 09; 18(9):e1003803. Hickey MD, Ayieko J, Owaraganise A, Sim N, Balzer LB, Kabami J, Atukunda M, Opel FJ, Wafula E, Nyabuti M, Brown L, Chamie G, Jain V, Peng J, Kwarisiima D, Camlin CS, Charlebois ED, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV. PMID: 34543267; PMCID: PMC8489716.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    77. Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment. PLoS One. 2021; 16(8):e0252095. Kerkhoff AD, Kagujje M, Nyangu S, Mateyo K, Sanjase N, Chilukutu L, Eshun-Wilson I, Geng EH, Havlir DV, Muyoyeta M. PMID: 34464392; PMCID: PMC8407587.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    78. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021 Sep 22; 13(612):eabh2624. van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Le Voyer T, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ, UCSF COMET consortium. PMID: 34429372; PMCID: PMC8601717.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    79. Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2021 08 01; 87(4):1024-1031. Jewell BL, Balzer LB, Clark TD, Charlebois ED, Kwarisiima D, Kamya MR, Havlir DV, Petersen ML, Bershteyn A. PMID: 33770065; PMCID: PMC8217115.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    80. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco. Clin Infect Dis. 2021 07 30; 73(Suppl 2):S127-S135. Chamie G, Marquez C, Crawford E, Peng J, Petersen M, Schwab D, Schwab J, Martinez J, Jones D, Black D, Gandhi M, Kerkhoff AD, Jain V, Sergi F, Jacobo J, Rojas S, Tulier-Laiwa V, Gallardo-Brown T, Appa A, Chiu C, Rodgers M, Hackett J, CLIAhub Consortium, Kistler A, Hao S, Kamm J, Dynerman D, Batson J, Greenhouse B, DeRisi J, Havlir DV. PMID: 32821935; PMCID: PMC7499499.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    81. Population HIV viral load metrics for community health. Lancet HIV. 2021 09; 8(9):e523-e524. Jain V, Petersen M, Havlir DV. PMID: 34331861.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    82. SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures. Arch Public Health. 2021 Jul 07; 79(1):125. Appa A, Chamie G, Sawyer A, Baltzell K, Dippell K, Ribeiro S, Duarte E, Vinden J, Consortium C, Kramer-Feldman J, Rahdari S, MacIntosh D, Nicholson K, Im J, Havlir D, Greenhouse B. PMID: 34233752; PMCID: PMC8261397.
      View in: PubMed   Mentions: 5  
    83. Social Networks and HIV Care Outcomes in Rural Kenya and Uganda. Epidemiology. 2021 07 01; 32(4):551-559. Chen YT, Brown L, Chamie G, Kwarisiima D, Ayieko J, Kabami J, Charlebois E, Clark T, Kamya M, Havlir DV, Petersen ML, Balzer LB. PMID: 33767114; PMCID: PMC8159862.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing. AIDS. 2021 07 01; 35(8):1241-1246. Imbert E, Hickey MD, Clemenzi-Allen A, Lynch E, Friend J, Kelley J, Conte M, Das D, Rosario JBD, Collins E, Oskarsson J, Hicks ML, Riley ED, Havlir DV, Gandhi M. PMID: 34076613; PMCID: PMC8186736.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    85. Decreased Time From Human Immunodeficiency Virus Diagnosis to Care, Antiretroviral Therapy Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. Clin Infect Dis. 2021 07 01; 73(1):e122-e128. Bacon O, Chin J, Cohen SE, Hessol NA, Sachdev D, Coffey S, Scheer S, Buchbinder S, Havlir DV, Hsu L. PMID: 32449916; PMCID: PMC8561247.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    86. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda. J Int AIDS Soc. 2021 06; 24(6):e25670. Ayieko J, Petersen ML, Kabami J, Mwangwa F, Opel F, Nyabuti M, Charlebois ED, Peng J, Koss CA, Balzer LB, Chamie G, Bukusi EA, Kamya MR, Havlir DV. PMID: 34152067; PMCID: PMC8215805.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    87. Dimensions of HIV-related stigma in rural communities in Kenya and Uganda at the start of a large HIV 'test and treat' trial. PLoS One. 2021; 16(5):e0249462. Akatukwasa C, Getahun M, El Ayadi AM, Namanya J, Maeri I, Itiakorit H, Owino L, Sanyu N, Kabami J, Ssemmondo E, Sang N, Kwarisiima D, Petersen ML, Charlebois ED, Chamie G, Clark TD, Cohen CR, Kamya MR, Bukusi EA, Havlir DV, Camlin CS. PMID: 33999961; PMCID: PMC8128261.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    88. Financial incentives and deposit contracts to promote HIV retesting in Uganda: A randomized trial. PLoS Med. 2021 05; 18(5):e1003630. Chamie G, Kwarisiima D, Ndyabakira A, Marson K, Camlin CS, Havlir DV, Kamya MR, Thirumurthy H. PMID: 33945526; PMCID: PMC8131095.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    89. Costs of integrating hypertension care into HIV care in rural East African clinics. AIDS. 2021 05 01; 35(6):911-919. Shade SB, Osmand T, Kwarisiima D, Brown LB, Luo A, Mwebaza B, Mwesigye AR, Kwizera E, Imukeka H, Mwanga F, Ayieko J, Owaraganise A, Bukusi EA, Cohen CR, Charlebois ED, Black D, Clark TD, Petersen ML, Kamya MR, Havlir DV, Jain V. PMID: 33821821; PMCID: PMC8030915.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco. Open Forum Infect Dis. 2021 Oct; 8(10):ofab202. Peng J, Marquez C, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Pilarowski G, Cox C, Derisi J, Havlir D, Petersen M. PMID: 34642635; PMCID: PMC8083232.
      View in: PubMed   Mentions: 5  
    91. Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco. J Infect Dis. 2021 04 08; 223(7):1139-1144. Pilarowski G, Lebel P, Sunshine S, Liu J, Crawford E, Marquez C, Rubio L, Chamie G, Martinez J, Peng J, Black D, Wu W, Pak J, Laurie MT, Jones D, Miller S, Jacobo J, Rojas S, Rojas S, Nakamura R, Tulier-Laiwa V, Petersen M, Havlir DV, DeRisi J. PMID: 33394052; PMCID: PMC7799021.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    92. CROI 2021: Tuberculosis, Opportunistic Infections, and COVID-19 Among People with HIV. Top Antivir Med. 2021 Apr-May; 29(2):344-351. Kerkhoff AD, Havlir DV. PMID: 34107204; PMCID: PMC8224244.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    93. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Lancet Infect Dis. 2021 07; 21(7):929-938. Kiang MV, Chin ET, Huynh BQ, Chapman LAC, Rodríguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC. PMID: 33765417; PMCID: PMC7984872.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsPHPublic Health
    94. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs. bioRxiv. 2021 Mar 10. van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Le Voyer T, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, UCSF COMET consortium, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ. PMID: 33758859; PMCID: PMC7987018.
      View in: PubMed   Mentions: 1  
    95. Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco. medRxiv. 2021 Mar 03. Peng J, Mann SA, Mitchell AM, Liu J, Laurie MT, Sunshine S, Pilarowski G, Ayscue P, Kistler A, Vanaerschot M, Li LM, McGeever A, Chow ED, Team I, Marquez C, Nakamura R, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Naso J, Schwab J, Petersen M, Havlir D, DeRisi J. PMID: 33688689; PMCID: PMC7941666.
      View in: PubMed   Mentions: 1  
    96. Progress in HIV care outcomes among Black men in San Francisco. Lancet HIV. 2021 03; 8(3):e126. Scheer S, LeSarre M, Liebi C, Havlir D, Buchbinder S. PMID: 33662263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based program. AIDS. 2021 03 01; 35(3):517-519. Hickey MD, Imbert E, Glidden DV, Del Rosario JB, Chong M, Clemenzi-Allen A, Oskarsson J, Riley ED, Gandhi M, Havlir DV. PMID: 33306555; PMCID: PMC7861117.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    98. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. PLoS Med. 2021 02; 18(2):e1003492. Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Chamie G, Atukunda M, Mwinike Y, Mwangwa F, Owaraganise A, Peng J, Olilo W, Snyman K, Awuonda B, Clark TD, Black D, Nugent J, Brown LB, Marquez C, Okochi H, Zhang K, Camlin CS, Jain V, Gandhi M, Cohen CR, Bukusi EA, Charlebois ED, Petersen ML, Kamya MR, Balzer LB. PMID: 33561143; PMCID: PMC7872279.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    99. Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya. PLoS One. 2021; 16(2):e0243167. Nyabuti MN, Petersen ML, Bukusi EA, Kamya MR, Mwangwa F, Kabami J, Sang N, Charlebois ED, Balzer LB, Schwab JD, Camlin CS, Black D, Clark TD, Chamie G, Havlir DV, Ayieko J. PMID: 33544717; PMCID: PMC7864429.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    100. Taking Vaccine to Where the Virus Is-Equity and Effectiveness in Coronavirus Vaccinations. JAMA Health Forum. 2021 Feb 01; 2(2):e210213. Bibbins-Domingo K, Petersen M, Havlir D. PMID: 36218794.
      View in: PubMed   Mentions: 17     Fields:    
    101. The COVID-19 Symptom to Isolation Cascade in a Latinx Community: A Call to Action. Open Forum Infect Dis. 2021 Feb; 8(2):ofab023. Rubio LA, Peng J, Rojas S, Rojas S, Crawford E, Black D, Jacobo J, Tulier-Laiwa V, Hoover CM, Martinez J, Jones D, Sachdev D, Cox C, Herrera E, Valencia R, Zurita KG, Chamie G, CLIAHUB Consortium, DeRisi J, Petersen M, Havlir DV, Marquez C. PMID: 33623805; PMCID: PMC7888566.
      View in: PubMed   Mentions: 12  
    102. Provider and Patient Perspectives of Rapid ART Initiation and Streamlined HIV Care: Qualitative Insights From Eastern African Communities. J Int Assoc Provid AIDS Care. 2021 Jan-Dec; 20:23259582211053518. Mwangwa F, Getahun M, Itiakorit H, Jain V, Ayieko J, Owino L, Akatukwasa C, Maeri I, Koss CA, Chamie G, Clark TD, Kabami J, Atukunda M, Kwarisiima D, Sang N, Bukusi EA, Kamya MR, Petersen ML, Cohen CR, Charlebois ED, Havlir DV, Camlin CS. PMID: 34841945; PMCID: PMC8641109.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    103. Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV. J Telemed Telecare. 2023 Apr; 29(3):187-195. Hickey MD, Sergi F, Zhang K, Spinelli MA, Black D, Sola C, Blaz V, Nguyen JQ, Oskarsson J, Gandhi M, Havlir DV. PMID: 33342328; PMCID: PMC8214632.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    104. Improved Viral Suppression With Streamlined Care in the SEARCH Study. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):571-578. Hickey MD, Ayieko J, Kwarisiima D, Opel FJ, Owaraganise A, Balzer LB, Chamie G, Jain V, Peng J, Camlin C, Charlebois ED, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV. PMID: 32991337; PMCID: PMC7654939.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    105. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation analysis. medRxiv. 2020 Dec 11. Kiang MV, Chin ET, Huynh BQ, Chapman LAC, Rodríguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC. PMID: 33330886; PMCID: PMC7743095.
      View in: PubMed   Mentions:
    106. Infant sex modifies associations between placental malaria and risk of malaria in infancy. Malar J. 2020 Dec 03; 19(1):449. Kakuru A, Roh ME, Kajubi R, Ochieng T, Ategeka J, Ochokoru H, Nakalembe M, Clark TD, Ruel T, Staedke SG, Chandramohan D, Havlir DV, Kamya MR, Dorsey G, Jagannathan P. PMID: 33272281; PMCID: PMC7713316.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    107. Machine Learning to Identify Persons at High-Risk of Human Immunodeficiency Virus Acquisition in Rural Kenya and Uganda. Clin Infect Dis. 2020 12 03; 71(9):2326-2333. Balzer LB, Havlir DV, Kamya MR, Chamie G, Charlebois ED, Clark TD, Koss CA, Kwarisiima D, Ayieko J, Sang N, Kabami J, Atukunda M, Jain V, Camlin CS, Cohen CR, Bukusi EA, Van Der Laan M, Petersen ML. PMID: 31697383; PMCID: PMC7904068.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    108. Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment. J Acquir Immune Defic Syndr. 2020 12 01; 85(4):444-449. Conte M, Eshun-Wilson I, Geng E, Imbert E, Hickey MD, Havlir D, Gandhi M, Clemenzi-Allen A. PMID: 33136742; PMCID: PMC8028840.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    109. Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020 12 01; 34(15):2328-2331. Spinelli MA, Hickey MD, Glidden DV, Nguyen JQ, Oskarsson JJ, Havlir D, Gandhi M. PMID: 32910069; PMCID: PMC7674255.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsPHPublic Health
    110. Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women. Antimicrob Agents Chemother. 2020 11 17; 64(12). Hughes E, Imperial M, Wallender E, Kajubi R, Huang L, Jagannathan P, Zhang N, Kakuru A, Natureeba P, Mwima MW, Muhindo M, Mwebaza N, Clark TD, Opira B, Nakalembe M, Havlir D, Kamya M, Rosenthal PJ, Dorsey G, Aweeka F, Savic RM. PMID: 33020153; PMCID: PMC7674024.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco. medRxiv. 2020 Nov 12. Pilarowski G, Lebel P, Sunshine S, Liu J, Crawford E, Marquez C, Rubio L, Chamie G, Martinez J, Peng J, Black D, Wu W, Pak J, Laurie MT, Jones D, Miller S, Jacobo J, Rojas S, Rojas S, Nakamura R, Tulier-Laiwa V, Petersen M, Havlir DV, CLIAHUB Consortium, DeRisi J. PMID: 33173911; PMCID: PMC7654907.
      View in: PubMed   Mentions: 7  
    112. HIV retesting and risk behaviors among high-risk, HIV-uninfected adults in Uganda. AIDS Care. 2021 05; 33(5):675-681. Marson K, Ndyabakira A, Kwarisiima D, Camlin CS, Kamya MR, Havlir D, Thirumurthy H, Chamie G. PMID: 33172300; PMCID: PMC8068573.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    113. Planning prompts to promote uptake of HIV services among men: a randomised trial in rural Uganda. BMJ Glob Health. 2020 11; 5(11). Kavanagh NM, Schaffer EM, Ndyabakira A, Marson K, Havlir DV, Kamya MR, Kwarisiima D, Chamie G, Thirumurthy H. PMID: 33257417; PMCID: PMC7705572.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    114. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa531. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, Havlir D, Greenhouse B. PMID: 34109255; PMCID: PMC7665736.
      View in: PubMed   Mentions: 8  
    115. Evaluation of a novel community-based COVID-19 'Test-to-Care' model for low-income populations. PLoS One. 2020; 15(10):e0239400. Kerkhoff AD, Sachdev D, Mizany S, Rojas S, Gandhi M, Peng J, Black D, Jones D, Rojas S, Jacobo J, Tulier-Laiwa V, Petersen M, Martinez J, Chamie G, Havlir DV, Marquez C. PMID: 33035216; PMCID: PMC7546468.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsPHPublic Health
    116. Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age. PLoS One. 2020; 15(10):e0240157. Zakama AK, Weekes T, Kajubi R, Kakuru A, Ategeka J, Kamya M, Muhindo MK, Havlir D, Jagannathan P, Dorsey G, Gaw SL. PMID: 33007041; PMCID: PMC7531849.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    117. Far from MCAR: Obtaining Population-level Estimates of HIV Viral Suppression. Epidemiology. 2020 09; 31(5):620-627. Balzer LB, Ayieko J, Kwarisiima D, Chamie G, Charlebois ED, Schwab J, van der Laan MJ, Kamya MR, Havlir DV, Petersen ML. PMID: 32452912; PMCID: PMC8105880.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    118. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. medRxiv. 2020 Aug 17. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Consortium C, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, Havlir D, Greenhouse B. PMID: 32839781; PMCID: PMC7444294.
      View in: PubMed   Mentions:
    119. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial. BMC Med. 2020 08 10; 18(1):207. Kakuru A, Jagannathan P, Kajubi R, Ochieng T, Ochokoru H, Nakalembe M, Clark TD, Ruel T, Staedke SG, Chandramohan D, Havlir DV, Kamya MR, Dorsey G. PMID: 32772921; PMCID: PMC7416391.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    120. Gravidity-dependent associations between interferon response and birth weight in placental malaria. Malar J. 2020 Aug 05; 19(1):280. Quanquin NM, Barres LG, Aliyari SR, Day NT, Gerami H, Fisher SJ, Kakuru A, Kamya MR, Havlir DV, Feeney M, Dorsey G, Cheng G, Gaw SL. PMID: 32758231; PMCID: PMC7409479.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    121. Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study. Curr HIV/AIDS Rep. 2020 08; 17(4):315-323. Chamie G, Hickey MD, Kwarisiima D, Ayieko J, Kamya MR, Havlir DV. PMID: 32507985; PMCID: PMC7731058.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    122. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial. AIDS. 2020 07 15; 34(9):1407-1415. Kabami J, Balzer LB, Saddiki H, Ayieko J, Kwarisiima D, Atukunda M, Charlebois ED, Clark TD, Koss CA, Ruel T, Bukusi EA, Cohen CR, Musoke P, Petersen ML, Havlir DV, Kamya MR, Chamie G. PMID: 32472768; PMCID: PMC7360881.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study. AIDS Behav. 2020 Jul; 24(7):2149-2162. Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, Maeri I, Bakanoma R, Onyango A, Atwine F, Ayieko J, Kabami J, Mwangwa F, Atukunda M, Owaraganise A, Kwarisiima D, Sang N, Bukusi EA, Kamya MR, Petersen ML, Cohen CR, Charlebois ED, Havlir DV. PMID: 31955361; PMCID: PMC7909847.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    124. The impact of gravidity, symptomatology and timing of infection on placental malaria. Malar J. 2020 Jun 24; 19(1):227. Tran EE, Cheeks ML, Kakuru A, Muhindo MK, Natureeba P, Nakalembe M, Ategeka J, Nayebare P, Kamya M, Havlir D, Feeney ME, Dorsey G, Gaw SL. PMID: 32580739; PMCID: PMC7315526.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    125. Virtual CROI 2020: Tuberculosis and Coinfections In HIV Infection. Top Antivir Med. 2020 Jun; 28(2):455-458. Kerkhoff AD, Havlir DV. PMID: 32886465; PMCID: PMC7482985.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    126. Improving Care Outcomes for PLWH Experiencing Homelessness and Unstable Housing: a Synthetic Review of Clinic-Based Strategies. Curr HIV/AIDS Rep. 2020 06; 17(3):259-267. Clemenzi-Allen AA, Hickey M, Conte M, Das D, Geng E, Riley E, Havlir D, Gandhi M, Imbert E. PMID: 32382919; PMCID: PMC8045147.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    127. SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures. medRxiv. 2020 May 30. Appa A, Chamie G, Sawyer A, Baltzell K, Dippell K, Ribeiro S, Duarte E, Vinden J, CLIAHUB Consortium, Kramer-Feldman J, Rahdari S, MacIntosh D, Nicholson K, Im J, Havlir D, Greenhouse B. PMID: 32511482; PMCID: PMC7273250.
      View in: PubMed   Mentions:
    128. Screening for Covid-19 in Skilled Nursing Facilities. Reply. N Engl J Med. 2020 07 09; 383(2):192-193. Gandhi M, Yokoe DS, Havlir DV. PMID: 32469484.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    129. A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda. PLoS One. 2020; 15(5):e0233600. Chamie G, Ndyabakira A, Marson KG, Emperador DM, Kamya MR, Havlir DV, Kwarisiima D, Thirumurthy H. PMID: 32470089; PMCID: PMC7259772.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    130. The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018. Am J Trop Med Hyg. 2020 08; 103(2):785-792. Kamya MR, Kakuru A, Muhindo M, Arinaitwe E, Nankabirwa JI, Rek J, Bigira V, Kapisi J, Wanzira H, Achan J, Natureeba P, Gasasira A, Havlir D, Jagannathan P, Rosenthal PJ, Rodriguez-Barraquer I, Dorsey G. PMID: 32431280; PMCID: PMC7410449.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    131. Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy. Curr Dev Nutr. 2020 May; 4(5):nzaa075. Finkelstein JL, Herman HS, Plenty A, Mehta S, Natureeba P, Clark TD, Kamya MR, Ruel T, Charlebois ED, Cohan D, Havlir D, Young SL. PMID: 32440638; PMCID: PMC7229869.
      View in: PubMed   Mentions: 4  
    132. Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19. N Engl J Med. 2020 05 28; 382(22):2158-2160. Gandhi M, Yokoe DS, Havlir DV. PMID: 32329972; PMCID: PMC7200054.
      View in: PubMed   Mentions: 574     Fields:    Translation:CellsPHPublic Health
    133. The Time for Universal Masking of the Public for Coronavirus Disease 2019 Is Now. Open Forum Infect Dis. 2020 Apr; 7(4):ofaa131. Gandhi M, Havlir D. PMID: 32346544; PMCID: PMC7179801.
      View in: PubMed   Mentions: 8  
    134. The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study. PLoS One. 2020; 15(3):e0229649. Muiru AN, Charlebois ED, Balzer LB, Kwarisiima D, Elly A, Black D, Okiror S, Kabami J, Atukunda M, Snyman K, Petersen M, Kamya M, Havlir D, Estrella MM, Hsu CY. PMID: 32130245; PMCID: PMC7055898.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    135. Putting women in the centre of the global HIV response is key to achieving epidemic control! J Int AIDS Soc. 2020 03; 23(3):e25473. Abdool Karim Q, Havlir D, Phanuphak N. PMID: 32142213; PMCID: PMC7059773.
      View in: PubMed   Mentions: 8     Fields:    
    136. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2020 03 01; 34(3):405-413. Puryear SB, Balzer LB, Ayieko J, Kwarisiima D, Hahn JA, Charlebois ED, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV, Chamie G. PMID: 31725431; PMCID: PMC7046088.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    137. Men's Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda. AIDS Behav. 2020 Mar; 24(3):967-974. Ndyabakira A, Chamie G, Emperador D, Marson K, Kamya MR, Havlir DV, Kwarisiima D, Thirumurthy H. PMID: 31073946.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    138. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020 04; 7(4):e249-e261. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, Atukunda M, Mwangwa F, Peng J, Mwinike Y, Owaraganise A, Chamie G, Jain V, Sang N, Olilo W, Brown LB, Marquez C, Zhang K, Ruel TD, Camlin CS, Rooney JF, Black D, Clark TD, Gandhi M, Cohen CR, Bukusi EA, Petersen ML, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 32087152; PMCID: PMC7208546.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCellsPHPublic Health
    139. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines. Lancet HIV. 2020 03; 7(3):e193-e200. Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio S. PMID: 32035041; PMCID: PMC7167509.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    140. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? J Int AIDS Soc. 2020 02; 23(2):e25455. Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G, Gaolathe T, Iwuji C, Fidler S, Kamya M, Floyd S, Moore J, Hayes R, Petersen M, Dabis F, (Universal Test, Treat Trials) UT3 Consortium. PMID: 32091179; PMCID: PMC7038879.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansPHPublic Health
    141. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa. AIDS. 2020 02 01; 34(2):311-315. Lesosky M, Raboud JM, Glass T, Brummel SS, Ciaranello AL, Currier JS, Essajee S, Havlir DV, Koss CA, Ogwu A, Shapiro RL, Abrams EJ, Myer L. PMID: 31634186; PMCID: PMC7060505.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    142. The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda. PLoS One. 2020; 15(1):e0228102. Marquez C, Atukunda M, Balzer LB, Chamie G, Kironde J, Ssemmondo E, Ruel TD, Mwangwa F, Tram KH, Clark TD, Kwarisiima D, Petersen M, Kamya MR, Charlebois ED, Havlir DV. PMID: 31995631; PMCID: PMC6988961.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    143. Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation. PLoS One. 2020; 15(1):e0222801. Heller DJ, Balzer LB, Kazi D, Charlebois ED, Kwarisiima D, Mwangwa F, Jain V, Kotwani P, Chamie G, Cohen CR, Clark TD, Ayieko J, Byonanabye DM, Petersen M, Kamya MR, Havlir D, Kahn JG. PMID: 31940346; PMCID: PMC6961918.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    144. The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):9-15. Brown LB, Balzer LB, Kabami J, Kwarisiima D, Sang N, Ayieko J, Chen Y, Chamie G, Charlebois ED, Camlin CS, Cohen CR, Bukusi E, Kamya MR, Moody J, Havlir DV, Petersen ML. PMID: 31809357; PMCID: PMC7793612.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. The Golden Compass Program: Overview of the Initial Implementation of a Comprehensive Program for Older Adults Living with HIV. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220935267. Greene M, Myers J, Tan JY, Blat C, O'Hollaren A, Quintanilla F, Hsue P, Shiels M, Hicks ML, Olson B, Grochowski J, Oskarsson J, Havlir D, Gandhi M. PMID: 32715875; PMCID: PMC7385829.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    146. Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda. BMC Public Health. 2019 Dec 30; 19(1):1763. Ndyabakira A, Getahun M, Byamukama A, Emperador D, Kabageni S, Marson K, Kwarisiima D, Chamie G, Thirumurthy H, Havlir D, Kamya MR, Camlin CS. PMID: 31888589; PMCID: PMC6937741.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    147. Getting to Zero San Francisco: A Collective Impact Approach. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S176-S182. Buchbinder SP, Havlir DV. PMID: 31764252; PMCID: PMC6880800.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    148. Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya. J Acquir Immune Defic Syndr. 2019 12 01; 82(4):e50-e53. Olilo WA, Petersen ML, Koss CA, Wafula E, Kwarisiima D, Kadede K, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Charlebois ED, Havlir DV, Ayieko J, SEARCH Collaboration. PMID: 31490343; PMCID: PMC6831040.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    149. Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial. Curr Opin HIV AIDS. 2019 11; 14(6):449-454. Chamie G, Kamya MR, Petersen ML, Havlir DV. PMID: 31589172; PMCID: PMC6798741.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsPHPublic Health
    150. Ending AIDS in the United States-If Not Now, When? JAMA Intern Med. 2019 Sep 01; 179(9):1165-1166. Havlir DV, Buchbinder SP. PMID: 31184750.
      View in: PubMed   Mentions: 2     Fields:    
    151. Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city. AIDS. 2019 09 01; 33(11):1789-1794. Spinelli MA, Hessol NA, Schwarcz S, Hsu L, Parisi MK, Pipkin S, Scheer S, Havlir D, Buchbinder SP. PMID: 31259765; PMCID: PMC6663574.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    152. Global HIV Treatment - Turning Headwinds to Tailwinds. N Engl J Med. 2019 08 29; 381(9):873-874. Havlir DV, Doherty MC. PMID: 31339675.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    153. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. N Engl J Med. 2019 07 18; 381(3):219-229. Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, Kabami J, Sang N, Liegler T, Chamie G, Camlin CS, Jain V, Kadede K, Atukunda M, Ruel T, Shade SB, Ssemmondo E, Byonanebye DM, Mwangwa F, Owaraganise A, Olilo W, Black D, Snyman K, Burger R, Getahun M, Achando J, Awuonda B, Nakato H, Kironde J, Okiror S, Thirumurthy H, Koss C, Brown L, Marquez C, Schwab J, Lavoy G, Plenty A, Mugoma Wafula E, Omanya P, Chen YH, Rooney JF, Bacon M, van der Laan M, Cohen CR, Bukusi E, Kamya MR, Petersen M. PMID: 31314966; PMCID: PMC6748325.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansPHPublic Health
    154. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. Lancet Infect Dis. 2019 09; 19(9):962-972. Muhindo MK, Jagannathan P, Kakuru A, Opira B, Olwoch P, Okiring J, Nalugo N, Clark TD, Ruel T, Charlebois E, Feeney ME, Havlir DV, Dorsey G, Kamya MR. PMID: 31307883; PMCID: PMC6722008.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    155. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda. AIDS Care. 2020 01; 32(1):119-127. Tram KH, Mwangwa F, Chamie G, Atukunda M, Owaraganise A, Ayieko J, Jain V, Clark TD, Kwarisiima D, Petersen ML, Kamya MR, Charlebois ED, Havlir DV, Marquez C, SEARCH collaboration. PMID: 31181961; PMCID: PMC6883160.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    156. Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa. Health Place. 2019 05; 57:339-351. Camlin CS, Akullian A, Neilands TB, Getahun M, Bershteyn A, Ssali S, Geng E, Gandhi M, Cohen CR, Maeri I, Eyul P, Petersen ML, Havlir DV, Kamya MR, Bukusi EA, Charlebois ED. PMID: 31152972; PMCID: PMC6589115.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    157. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019 05 17; 68(11):1877-1886. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. PMID: 30219823; PMCID: PMC6522677.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    158. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health. 2019 May 06; 19(1):511. Kwarisiima D, Atukunda M, Owaraganise A, Chamie G, Clark T, Kabami J, Jain V, Byonanebye D, Mwangwa F, Balzer LB, Charlebois E, Kamya MR, Petersen M, Havlir DV, Brown LB. PMID: 31060545; PMCID: PMC6501396.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    159. Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole. Sci Rep. 2019 05 01; 9(1):6758. McDonald CR, Weckman AM, Conroy AL, Olwoch P, Natureeba P, Kamya MR, Havlir DV, Dorsey G, Kain KC. PMID: 31043691; PMCID: PMC6494863.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    160. A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome. Int J Infect Dis. 2019 Jul; 84:30-38. Silva CAM, Graham B, Webb K, Ashton LV, Harton M, Luetkemeyer AF, Bokatzian S, Almubarak R, Mahapatra S, Hovind L, Kendall MA, Havlir D, Belisle JT, De Groote MA. PMID: 31009738; PMCID: PMC6613934.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    161. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019 04; 22(4):e25276. Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, Kamya MR, Petersen ML, Havlir DV, Jewell BL. PMID: 31037845; PMCID: PMC6488759.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    162. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya. J Acquir Immune Defic Syndr. 2019 04 01; 80(4):414-422. Ayieko J, Petersen ML, Charlebois ED, Brown LB, Clark TD, Kwarisiima D, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Van Rie A. PMID: 30807481; PMCID: PMC6410970.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    163. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 04 01; 33(5):825-832. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. PMID: 30882490; PMCID: PMC7029629.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    164. CROI 2019: complications and coinfections in HIV infection. Top Antivir Med. 2019 Apr; 27(1):34-40. Currier JS, Havlir DV. PMID: 31137001; PMCID: PMC6550358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    165. Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort. Open Forum Infect Dis. 2019 May; 6(5):ofz148. Clemenzi-Allen A, Neuhaus J, Geng E, Sachdev D, Buchbinder S, Havlir D, Gandhi M, Christopoulos K. PMID: 31139668; PMCID: PMC6534280.
      View in: PubMed   Mentions: 13  
    166. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019 Apr 06; 393(10179):1428-1439. Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, Opira B, Ochokoru H, Ategeka J, Nayebare P, Clark TD, Havlir DV, Kamya MR, Dorsey G. PMID: 30910321.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    167. Closing the gap: A novel metric of change in performance. East Afr J Appl Health Monitor Eval. 2019 Feb; 2019(3). Katuramu R, Wallenta J, Semitala FC, Amanyire G, Kampiire L, Namusobya J, Kamya MR, Havlir D, Glidden DV, Geng E. PMID: 32817932; PMCID: PMC7428843.
      View in: PubMed   Mentions: 1  
    168. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda. Antimicrob Agents Chemother. 2019 02; 63(2). Wallender E, Zhang N, Conrad M, Kakuru A, Muhindo M, Tumwebaze P, Kajubi R, Mota D, Legac J, Jagannathan P, Havlir D, Kamya M, Dorsey G, Aweeka F, Rosenthal PJ, Savic RM. PMID: 30530597; PMCID: PMC6355581.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    169. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis. PLoS One. 2019; 14(1):e0210126. Brown LB, Getahun M, Ayieko J, Kwarisiima D, Owaraganise A, Atukunda M, Olilo W, Clark T, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV, Camlin CS. PMID: 30673744; PMCID: PMC6343966.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    170. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. Lancet HIV. 2019 03; 6(3):e155-e163. Thirumurthy H, Ndyabakira A, Marson K, Emperador D, Kamya M, Havlir D, Kwarisiima D, Chamie G. PMID: 30660594; PMCID: PMC6421075.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    171. Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco. PLoS One. 2018; 13(12):e0208486. Greene ML, Tan JY, Weiser SD, Christopoulos K, Shiels M, O'Hollaren A, Mureithi E, Meissner L, Havlir D, Gandhi M. PMID: 30517193; PMCID: PMC6281256.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    172. Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda. Pediatr Infect Dis J. 2018 12; 37(12):1279-1281. Ayieko J, Chamie G, Balzer L, Kwarisiima D, Kabami J, Sang N, Cohen CR, Bukusi EA, Clark TD, Plenty A, Charlebois ED, Petersen M, Kamya M, Havlir DV, Ruel T. PMID: 30199482; PMCID: PMC6226337.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    173. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Lancet HIV. 2019 Feb; 6(2):e116-e127. Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A. PMID: 30503325; PMCID: PMC6361866.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    174. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. PMID: 30503324; PMCID: PMC6541554.
      View in: PubMed   Mentions: 28     Fields:    
    175. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda. Clin Infect Dis. 2018 11 28; 67(12):1853-1860. Koss CA, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Balzer LB, Plenty A, Sang N, Kabami J, Ruel TD, Black D, Camlin CS, Cohen CR, Bukusi EA, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 29741594; PMCID: PMC6260162.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    176. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys. AIDS. 2018 09 24; 32(15):2179-2188. Shade SB, Osmand T, Luo A, Aine R, Assurah E, Mwebaza B, Mwai D, Owaraganise A, Mwangwa F, Ayieko J, Black D, Brown LB, Clark TD, Kwarisiima D, Thirumurthy H, Cohen CR, Bukusi EA, Charlebois ED, Balzer L, Kamya MR, Petersen ML, Havlir DV, Jain V. PMID: 30134294; PMCID: PMC6143350.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    177. Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. Clin Infect Dis. 2018 09 14; 67(7):1079-1088. Savic RM, Jagannathan P, Kajubi R, Huang L, Zhang N, Were M, Kakuru A, Muhindo MK, Mwebaza N, Wallender E, Clark TD, Opira B, Kamya M, Havlir DV, Rosenthal PJ, Dorsey G, Aweeka FT. PMID: 29547881; PMCID: PMC6137112.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    178. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018; 13(8):e0202990. Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, Petersen ML, Clark TD, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Camlin CS. PMID: 30161172; PMCID: PMC6116983.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    179. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018 07 28; 392(10144):312-358. Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. PMID: 30032975; PMCID: PMC6323648.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    180. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002606. Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G. PMID: 30016328; PMCID: PMC6049882.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    181. Comparative effectiveness of novel nonmonetary incentives to promote HIV testing. AIDS. 2018 07 17; 32(11):1443-1451. Chamie G, Schaffer EM, Ndyabakira A, Emperador DM, Kwarisiima D, Camlin CS, Havlir DV, Kahn JG, Kamya MR, Thirumurthy H. PMID: 29683850; PMCID: PMC6112858.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    182. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial. PLoS One. 2018; 13(6):e0198912. Jakubowski A, Snyman K, Kwarisiima D, Sang N, Burger R, Balzer L, Clark T, Chamie G, Shade S, Cohen C, Bukusi E, Charlebois E, Kamya M, Petersen M, Havlir D, Thirumurthy H. PMID: 29944678; PMCID: PMC6019679.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    183. Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural Kenya. Open Forum Infect Dis. 2018 Jun 01; 5(6):ofy126. Ayieko J, Petersen ML, van Rie A, Wafula E, Opudo W, Clark TD, Kamya MR, Balzer LB, Cohen CR, Bukusi EA, Charlebois ED, Havlir DV. PMID: 29977971; PMCID: PMC6007399.
      View in: PubMed   Mentions: 6  
    184. CROI 2018: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2018 May; 26(1):22-29. Currier JS, Havlir DV. PMID: 29727294; PMCID: PMC5963934.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    185. Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells. Pathog Immun. 2018; 3(1):46-62. Sattler FR, Chelliah D, Wu X, Sanchez A, Kendall MA, Hogg E, Lagat D, Lalloo U, Veloso V, Havlir DV, Landay A. PMID: 29770360; PMCID: PMC5951172.
      View in: PubMed   Mentions: 5  
    186. Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era. Clin Infect Dis. 2018 03 19; 66(7):1027-1034. Scheer S, Hsu L, Schwarcz S, Pipkin S, Havlir D, Buchbinder S, Hessol NA. PMID: 29099913; PMCID: PMC6248750.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    187. Degree of Housing Instability Shows Independent "Dose-Response" With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2018 Mar; 5(3):ofy035. Clemenzi-Allen A, Geng E, Christopoulos K, Hammer H, Buchbinder S, Havlir D, Gandhi M. PMID: 29577059; PMCID: PMC5850870.
      View in: PubMed   Mentions: 27  
    188. Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz. J Infect Dis. 2018 03 05; 217(6):964-972. Wallender E, Vucicevic K, Jagannathan P, Huang L, Natureeba P, Kakuru A, Muhindo M, Nakalembe M, Havlir D, Kamya M, Aweeka F, Dorsey G, Rosenthal PJ, Savic RM. PMID: 29272443; PMCID: PMC5853566.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    189. Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda. PLoS One. 2018; 13(2):e0192666. Chamie G, Kato-Maeda M, Emperador DM, Wandera B, Mugagga O, Crandall J, Janes M, Marquez C, Kamya MR, Charlebois ED, Havlir DV. PMID: 29438413; PMCID: PMC5811029.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    190. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. J Int AIDS Soc. 2018 01; 21(1). Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, Floyd S, Havlir D, Kamya M, Lebelonyane R, Mills LA, Okello V, Petersen M, Pillay D, Sabapathy K, Wirth K, Orne-Gliemann J, Dabis F, Universal Test and Treat Trials Consortium (UT3C). PMID: 29314658; PMCID: PMC5810333.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansPHPublic Health
    191. Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis. J Infect Dis. 2017 12 19; 216(12):1541-1549. Roh ME, Shiboski S, Natureeba P, Kakuru A, Muhindo M, Ochieng T, Plenty A, Koss CA, Clark TD, Awori P, Nakalambe M, Cohan D, Jagannathan P, Gosling R, Havlir DV, Kamya MR, Dorsey G. PMID: 29029337; PMCID: PMC5853907.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    192. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care. J Acquir Immune Defic Syndr. 2017 Dec 15; 76(5):e115-e117. Tram KH, Mwangwa F, Atukunda M, Owaraganise A, Ayieko J, Plenty A, Kwariisima D, Clark TD, Petersen ML, Charlebois ED, Kamya MR, Chamie G, Havlir DV, Marquez C, SEARCH Collaboration. PMID: 28885271; PMCID: PMC5680115.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    193. Redemption of the "spoiled identity:" the role of HIV-positive individuals in HIV care cascade interventions. J Int AIDS Soc. 2017 12; 20(4). Camlin CS, Charlebois ED, Geng E, Semitala F, Wallenta J, Getahun M, Kampiire L, Bukusi EA, Sang N, Kwarisiima D, Clark TD, Petersen ML, Kamya MR, Havlir DV. PMID: 29210185; PMCID: PMC5810337.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    194. Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry. J Int AIDS Soc. 2017 12; 20(4). Semitala FC, Camlin CS, Wallenta J, Kampiire L, Katuramu R, Amanyire G, Namusobya J, Chang W, Kahn JG, Charlebois ED, Havlir DV, Kamya MR, Geng EH. PMID: 29206357; PMCID: PMC5810312.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    195. Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya. J Clin Tuberc Other Mycobact Dis. 2017 Dec; 9:24-29. Mwangwa F, Chamie G, Kwarisiima D, Ayieko J, Owaraganise A, Ruel TD, Plenty A, Tram KH, Clark TD, Cohen CR, Bukusi EA, Petersen M, Kamya MR, Charlebois ED, Havlir DV, Marquez C. PMID: 29291251; PMCID: PMC5743212.
      View in: PubMed   Mentions: 10  
    196. Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study. Lancet HIV. 2018 03; 5(3):e146-e154. Phillips AN, Cambiano V, Nakagawa F, Revill P, Jordan MR, Hallett TB, Doherty M, De Luca A, Lundgren JD, Mhangara M, Apollo T, Mellors J, Nichols B, Parikh U, Pillay D, Rinke de Wit T, Sigaloff K, Havlir D, Kuritzkes DR, Pozniak A, van de Vijver D, Vitoria M, Wainberg MA, Raizes E, Bertagnolio S, Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saha. PMID: 29174084; PMCID: PMC5843989.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    197. Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda. J Infect Dis. 2017 11 15; 216(8):1008-1017. Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ. PMID: 28968782; PMCID: PMC5853776.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    198. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am J Obstet Gynecol. 2017 12; 217(6):684.e1-684.e17. Conroy AL, McDonald CR, Gamble JL, Olwoch P, Natureeba P, Cohan D, Kamya MR, Havlir DV, Dorsey G, Kain KC. PMID: 29031892; PMCID: PMC5723571.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    199. Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. Malar J. 2017 10 05; 16(1):400. Kapisi J, Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Ssekitoleko R, Olwoch P, Ategeka J, Nayebare P, Clark TD, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G, Gaw SL. PMID: 28982374; PMCID: PMC5629777.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    200. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):e15-e18. Brown LB, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, Ruel T, Clark T, Black D, Chamie G, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV. PMID: 28394821; PMCID: PMC5828506.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    201. The science of rapid start-From the when to the how of antiretroviral initiation. PLoS Med. 2017 Jul; 14(7):e1002358. Geng EH, Havlir DV. PMID: 28742819; PMCID: PMC5526524.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    202. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. J Int AIDS Soc. 2017 07 21; 20(Suppl 4):21673. Kwarisiima D, Kamya MR, Owaraganise A, Mwangwa F, Byonanebye DM, Ayieko J, Plenty A, Black D, Clark TD, Nzarubara B, Snyman K, Brown L, Bukusi E, Cohen CR, Geng EH, Charlebois ED, Ruel TD, Petersen ML, Havlir D, Jain V. PMID: 28770596; PMCID: PMC5577724.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    203. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women. J Infect Dis. 2017 07 01; 216(1):29-35. Natureeba P, Kakuru A, Muhindo M, Ochieng T, Ategeka J, Koss CA, Plenty A, Charlebois ED, Clark TD, Nzarubara B, Nakalembe M, Cohan D, Rizzuto G, Muehlenbachs A, Ruel T, Jagannathan P, Havlir DV, Kamya MR, Dorsey G. PMID: 28329368; PMCID: PMC5853208.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    204. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa. JAMA. 2017 Jun 06; 317(21):2196-2206. Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, Kabami J, Owaraganise A, Liegler T, Mwangwa F, Kadede K, Jain V, Plenty A, Brown L, Lavoy G, Schwab J, Black D, van der Laan M, Bukusi EA, Cohen CR, Clark TD, Charlebois E, Kamya M, Havlir D. PMID: 28586888; PMCID: PMC5734234.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    205. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. Clin Pharmacol Ther. 2017 Sep; 102(3):520-528. Kajubi R, Huang L, Jagannathan P, Chamankhah N, Were M, Ruel T, Koss CA, Kakuru A, Mwebaza N, Kamya M, Havlir D, Dorsey G, Rosenthal PJ, Aweeka FT. PMID: 28187497; PMCID: PMC5546920.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    206. CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment. Top Antivir Med. 2017 May/Jun; 25(2):77-83. Currier JS, Havlir DV. PMID: 28598792; PMCID: PMC5677045.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    207. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):279-284. Koss CA, Natureeba P, Kwarisiima D, Ogena M, Clark TD, Olwoch P, Cohan D, Okiring J, Charlebois ED, Kamya MR, Havlir DV. PMID: 27828878; PMCID: PMC5303140.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    208. Sex Disparity in Cord Blood FoxP3+ CD4 T Regulatory Cells in Infants Exposed to Malaria In Utero. Open Forum Infect Dis. 2017; 4(1):ofx022. Prahl M, Jagannathan P, McIntyre TI, Auma A, Wamala S, Nalubega M, Musinguzi K, Naluwu K, Sikyoma E, Budker R, Odorizzi P, Kakuru A, Havlir DV, Kamya MR, Dorsey G, Feeney ME. PMID: 28480292; PMCID: PMC5414097.
      View in: PubMed   Mentions: 7  
    209. The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting. J Acquir Immune Defic Syndr. 2017 Jan 01; 74(1):44-51. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. PMID: 27434707; PMCID: PMC5140684.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCells
    210. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis. Lancet HIV. 2017 03; 4(3):e122-e133. Jain V, Petersen ML, Liegler T, Byonanebye DM, Kwarisiima D, Chamie G, Sang N, Black D, Clark TD, Ladai A, Plenty A, Kabami J, Ssemmondo E, Bukusi EA, Cohen CR, Charlebois ED, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 27989576; PMCID: PMC5730457.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    211. Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy. Pediatr Infect Dis J. 2016 12; 35(12):1329-1332. Achan J, Kakuru A, Ikilezi G, Mwangwa F, Plenty A, Charlebois E, Young S, Havlir D, Kamya M, Ruel T. PMID: 27580060; PMCID: PMC5106322.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    212. High levels of retention in care with streamlined care and universal test and treat in East Africa. AIDS. 2016 11 28; 30(18):2855-2864. Brown LB, Havlir DV, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, Ruel T, Clark T, Chamie G, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, SEARCH Collaboration. PMID: 27603290; PMCID: PMC5332142.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    213. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J Acquir Immune Defic Syndr. 2016 Nov 01; 73(3):e39-e45. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. PMID: 27741031; PMCID: PMC5089839.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    214. Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda. J Acquir Immune Defic Syndr. 2016 Nov 01; 73(3):e46-e50. Ssemmondo E, Mwangwa F, Kironde JL, Kwarisiima D, Clark TD, Marquez C, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G, SEARCH Collaboration. PMID: 27741032; PMCID: PMC6269148.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    215. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting. Malar J. 2016 Oct 18; 15(1):500. Kakuru A, Natureeba P, Muhindo MK, Clark TD, Havlir DV, Cohan D, Dorsey G, Kamya MR, Ruel T. PMID: 27756308; PMCID: PMC5070200.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    216. Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation. Malar J. 2016 10 07; 15(1):497. Prahl M, Jagannathan P, McIntyre TI, Auma A, Farrington L, Wamala S, Nalubega M, Musinguzi K, Naluwu K, Sikyoma E, Budker R, Vance H, Odorizzi P, Nayebare P, Ategeka J, Kakuru A, Havlir DV, Kamya MR, Dorsey G, Feeney ME. PMID: 27717402; PMCID: PMC5055709.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    217. Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya. AIDS. 2016 09 10; 30(14):2121-6. Kadede K, Ruel T, Kabami J, Ssemmondo E, Sang N, Kwarisiima D, Bukusi E, Cohen CR, Liegler T, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G, SEARCH team. PMID: 27258399; PMCID: PMC5007167.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    218. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016 11; 3(11):e539-e548. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, Glidden D, Kamya M, Havlir D, Geng E. PMID: 27658873; PMCID: PMC5408866.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCTClinical Trials
    219. Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda. Malar J. 2016 Aug 26; 15(1):437. Muhindo MK, Kakuru A, Natureeba P, Awori P, Olwoch P, Ategeka J, Nayebare P, Clark TD, Muehlenbachs A, Roh M, Mpeka B, Greenhouse B, Havlir DV, Kamya MR, Dorsey G, Jagannathan P. PMID: 27566109; PMCID: PMC5002129.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsPHPublic Health
    220. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016 09 01; 375(9):830-9. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR, HPTN 052 Study Team. PMID: 27424812; PMCID: PMC5049503.
      View in: PubMed   Mentions: 718     Fields:    Translation:HumansCellsPHPublic Health
    221. Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS One. 2016; 11(7):e0158262. Saharia KK, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P, Luetkemeyer A, Havlir D, Koup RA. PMID: 27367521; PMCID: PMC4930205.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    222. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nat Med. 2016 07; 22(7):807-11. Li P, Kaiser P, Lampiris HW, Kim P, Yukl SA, Havlir DV, Greene WC, Wong JK. PMID: 27294875; PMCID: PMC5004598.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    223. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda. PLoS One. 2016; 11(5):e0156309. Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, Ayieko J, Mwangwa F, Jain V, Byonanebye D, Petersen M, Havlir D, Kamya MR. PMID: 27232186; PMCID: PMC4883789.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    224. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2016 May-Jun; 24(1):38-46. Havlir DV, Currier JS. PMID: 27398861; PMCID: PMC6148923.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    225. Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. Pediatr Infect Dis J. 2016 May; 35(5):524-9. Marquez C, Chamie G, Achan J, Luetkemeyer AF, Kyohere M, Okiring J, Dorsey G, Kamya MR, Charlebois ED, Havlir DV. PMID: 26771662; PMCID: PMC4829461.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    226. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med. 2016 Mar 10; 374(10):928-39. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G. PMID: 26962728; PMCID: PMC4847718.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    227. Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women. J Acquir Immune Defic Syndr. 2016 Mar 01; 71(3):310-5. Koss CA, Natureeba P, Nyafwono D, Plenty A, Mwesigwa J, Nzarubara B, Clark TD, Ruel TD, Achan J, Charlebois ED, Cohan D, Kamya MR, Havlir DV, Young SL. PMID: 26397935; PMCID: PMC4752388.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    228. Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda. J Infect Dis. 2016 06 15; 213(12):1971-8. Katrak S, Day N, Ssemmondo E, Kwarisiima D, Midekisa A, Greenhouse B, Kamya M, Havlir D, Dorsey G. PMID: 26908725; PMCID: PMC4878723.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    229. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016 May 01; 62(9):1081-8. Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D, AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams. PMID: 26839383; PMCID: PMC4826450.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    230. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016 Mar; 3(3):e111-9. Chamie G, Clark TD, Kabami J, Kadede K, Ssemmondo E, Steinfeld R, Lavoy G, Kwarisiima D, Sang N, Jain V, Thirumurthy H, Liegler T, Balzer LB, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Charlebois ED. PMID: 26939734; PMCID: PMC4780220.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansPHPublic Health
    231. "How can I tell?" Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV "test-and-treat" trial. AIDS Care. 2016; 28 Suppl 3:59-66. Maeri I, El Ayadi A, Getahun M, Charlebois E, Akatukwasa C, Tumwebaze D, Itiakorit H, Owino L, Kwarisiima D, Ssemmondo E, Sang N, Kabami J, Clark TD, Petersen M, Cohen CR, Bukusi EA, Kamya M, Havlir D, Camlin CS, SEARCH Collaboration. PMID: 27421052; PMCID: PMC5751752.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    232. Men "missing" from population-based HIV testing: insights from qualitative research. AIDS Care. 2016; 28 Suppl 3:67-73. Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, Kabami J, Charlebois E, Petersen M, Clark TD, Bukusi EA, Cohen CR, R Kamya M, Havlir D, SEARCH Collaboration. PMID: 27421053; PMCID: PMC5749410.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansPHPublic Health
    233. Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial. AIDS Care. 2016; 28 Suppl 3:90-8. Thirumurthy H, Jakubowski A, Camlin C, Kabami J, Ssemmondo E, Elly A, Mwai D, Clark T, Cohen C, Bukusi E, Kamya M, Petersen M, Havlir D, Charlebois ED. PMID: 27421056; PMCID: PMC5443252.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    234. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS One. 2015; 10(12):e0143433. Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG. PMID: 26632823; PMCID: PMC4669141.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    235. "I Have Remained Strong Because of That Food": Acceptability and Use of Lipid-Based Nutrient Supplements Among Pregnant HIV-Infected Ugandan Women Receiving Combination Antiretroviral Therapy. AIDS Behav. 2015 Aug; 19(8):1535-47. Young S, Natamba B, Luwedde F, Nyafwono D, Okia B, Osterbauer B, Natureeba P, Johnson L, Michel C, Zheng A, Robine M, Achan J, Charlebois E, Cohan D, Havlir D. PMID: 25416075; PMCID: PMC4441598.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    236. Implementation challenges for long-acting antivirals as treatment. Curr Opin HIV AIDS. 2015 Jul; 10(4):282-9. Havlir D, Gandhi M. PMID: 26049955; PMCID: PMC5847341.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    237. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS. 2015 Apr 24; 29(7):825-30. Koss CA, Natureeba P, Mwesigwa J, Cohan D, Nzarubara B, Bacchetti P, Horng H, Clark TD, Plenty A, Ruel TD, Achan J, Charlebois ED, Kamya MR, Havlir DV, Gandhi M. PMID: 25985404; PMCID: PMC4438773.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    238. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS One. 2015; 10(3):e0121290. Yukl SA, Shergill AK, Girling V, Li Q, Killian M, Epling L, Li P, Kaiser P, Haase A, Havlir DV, McQuaid K, Sinclair E, Wong JK. PMID: 25811360; PMCID: PMC4374729.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    239. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother. 2015; 59(6):3018-30. Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, Kozak B, Bloome J, Okiring J, Kakuru A, Bigira V, Kapisi J, Legac J, Gut J, Cooper RA, Kamya MR, Havlir DV, Dorsey G, Greenhouse B, Nsobya SL, Rosenthal PJ. PMID: 25753626; PMCID: PMC4432194.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimals
    240. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2015 Mar-Apr; 23(1):56-65. Havlir DV, Currier JS. PMID: 25965312; PMCID: PMC6148904.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    241. The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda. Pediatr Infect Dis J. 2015 Mar; 34(3):e63-70. Bartelink IH, Savic RM, Dorsey G, Ruel T, Gingrich D, Scherpbier HJ, Capparelli E, Jullien V, Young SL, Achan J, Plenty A, Charlebois E, Kamya M, Havlir D, Aweeka F. PMID: 25742090; PMCID: PMC4351793.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    242. Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. Clin Infect Dis. 2015 Jun 15; 60(12):1860-3. Luetkemeyer AF, Rosenkranz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron H, Havlir DV, Haas DW, Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams. PMID: 25722197; PMCID: PMC4542662.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    243. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach. Trop Med Int Health. 2015 Apr; 20(4):537-45. Chamie G, Wandera B, Marquez C, Kato-Maeda M, Kamya MR, Havlir DV, Charlebois ED. PMID: 25583212; PMCID: PMC4355181.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    244. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2015 Jan 14; 29(2):183-91. Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV. PMID: 25426808; PMCID: PMC4428759.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsPHPublic Health
    245. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial. AIDS. 2014 Nov 28; 28(18):2701-9. Kamya MR, Kapisi J, Bigira V, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Kakuru A, Aweeka FT, Huang L, Jagannathan P, Achan J, Havlir DV, Rosenthal PJ, Dorsey G. PMID: 25493596; PMCID: PMC4487368.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    246. Household food insecurity, maternal nutritional status, and infant feeding practices among HIV-infected Ugandan women receiving combination antiretroviral therapy. Matern Child Health J. 2014 Nov; 18(9):2044-53. Young SL, Plenty AH, Luwedde FA, Natamba BK, Natureeba P, Achan J, Mwesigwa J, Ruel TD, Ades V, Osterbauer B, Clark TD, Dorsey G, Charlebois ED, Kamya M, Havlir DV, Cohan DL. PMID: 24585398; PMCID: PMC4419705.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    247. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):128-35. Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D. PMID: 25072616; PMCID: PMC4414017.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    248. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda. AIDS. 2014 Sep 24; 28(15):2241-9. Jain V, Byonanebye DM, Amanyire G, Kwarisiima D, Black D, Kabami J, Chamie G, Clark TD, Rooney JF, Charlebois ED, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 25022596; PMCID: PMC4894849.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    249. Assessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural Uganda. PLoS One. 2014; 9(8):e105935. Marquez C, Davis JL, Katamba A, Haguma P, Ochom E, Ayakaka I, Chamie G, Dorsey G, Kamya MR, Charlebois E, Havlir DV, Cattamanchi A. PMID: 25170875; PMCID: PMC4149493.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    250. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One. 2014; 9(8):e105690. Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, Dorsey G, Rosenthal PJ. PMID: 25144768; PMCID: PMC4140830.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    251. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr. 2014 Dec; 60(6):434-41. Marquez C, Okiring J, Chamie G, Ruel TD, Achan J, Kakuru A, Kamya MR, Charlebois ED, Havlir DV, Dorsey G. PMID: 25145704; PMCID: PMC4303769.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    252. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial. PLoS Med. 2014 Aug; 11(8):e1001689. Bigira V, Kapisi J, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Osterbauer B, Aweeka FT, Huang L, Achan J, Havlir DV, Rosenthal PJ, Kamya MR, Dorsey G. PMID: 25093754; PMCID: PMC4122345.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    253. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. J Infect Dis. 2014 Dec 15; 210(12):1938-45. Natureeba P, Ades V, Luwedde F, Mwesigwa J, Plenty A, Okong P, Charlebois ED, Clark TD, Nzarubara B, Havlir DV, Achan J, Kamya MR, Cohan D, Dorsey G. PMID: 24958908; PMCID: PMC4296178.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    254. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2014 May; 22(2):602-15. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 24901886; PMCID: PMC6148912.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    255. Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. Clin Infect Dis. 2014 Aug 01; 59(3):446-53. Kakuru A, Achan J, Muhindo MK, Ikilezi G, Arinaitwe E, Mwangwa F, Ruel T, Clark TD, Charlebois E, Rosenthal PJ, Havlir D, Kamya MR, Tappero JW, Dorsey G. PMID: 24759826; PMCID: PMC4155440.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    256. Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):535-41. Ruel TD, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Kamya M, Achan J. PMID: 24326597; PMCID: PMC3999287.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    257. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):423-8. Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J, Adult AIDS Clinical Trials Group A5221 Study Team. PMID: 24226057; PMCID: PMC3943693.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    258. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014 Apr; 14(4):281-90. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS, HPTN 052-ACTG Study Team. PMID: 24602844; PMCID: PMC4144040.
      View in: PubMed   Mentions: 271     Fields:    Translation:HumansCellsCTClinical Trials
    259. Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy access. J Acquir Immune Defic Syndr. 2014 Mar 01; 65(3):327-32. Jain V, Byonanebye DM, Liegler T, Kwarisiima D, Chamie G, Kabami J, Petersen ML, Balzer LB, Clark TD, Black D, Thirumurthy H, Geng EH, Charlebois ED, Amanyire G, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 24146022; PMCID: PMC4172444.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    260. Evaluating linkage to care for hypertension after community-based screening in rural Uganda. Trop Med Int Health. 2014 Apr; 19(4):459-68. Kotwani P, Balzer L, Kwarisiima D, Clark TD, Kabami J, Byonanebye D, Bainomujuni B, Black D, Chamie G, Jain V, Thirumurthy H, Kamya MR, Geng EH, Petersen ML, Havlir DV, Charlebois ED, SEARCH Collaboration. PMID: 24495307; PMCID: PMC4118739.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    261. A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. AIDS. 2014 Jan 28; 28(3):439-42. Yukl SA, Sinclair E, Somsouk M, Hunt PW, Epling L, Killian M, Girling V, Li P, Havlir DV, Deeks SG, Wong JK, Hatano H. PMID: 24322272; PMCID: PMC4130176.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    262. Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. Am J Cardiol. 2014 Apr 01; 113(7):1260-5. Moyers BS, Secemsky EA, Vittinghoff E, Wong JK, Havlir DV, Hsue PY, Tseng ZH. PMID: 24521717; PMCID: PMC3959566.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    263. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol. 2014 Apr; 52(4):1052-9. Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, Qasba SS, Sanchez J, Havlir DV, Grinsztejn B, Sanne IM, Firnhaber C, Adult AIDS Clinical Trials Group A5255 Study Team. PMID: 24430455; PMCID: PMC3993501.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    264. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One. 2014; 9(1):e84317. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Balzer LB, Petersen ML, Thirumurthy H, Charlebois ED, Kamya MR, Havlir DV. PMID: 24392124; PMCID: PMC3879307.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansPHPublic Health
    265. Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study. BMC Public Health. 2013 Dec 09; 13:1151. Kotwani P, Kwarisiima D, Clark TD, Kabami J, Geng EH, Jain V, Chamie G, Petersen ML, Thirumurthy H, Kamya MR, Charlebois ED, Havlir DV, SEARCH Collaboration. PMID: 24321133; PMCID: PMC3890617.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    266. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013 Nov 02; 382(9903):1525-33. Deeks SG, Lewin SR, Havlir DV. PMID: 24152939; PMCID: PMC4058441.
      View in: PubMed   Mentions: 747     Fields:    Translation:Humans
    267. Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS. Clin Infect Dis. 2013 Dec; 57(12):1766-72. Vijayan T, Semitala FC, Matsiko N, Elyanu P, Namusobya J, Havlir DV, Kamya M, Geng EH. PMID: 24065326; PMCID: PMC3840406.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    268. Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda. J Clin Pharmacol. 2014 Feb; 54(2):121-32. Bartelink IH, Savic RM, Mwesigwa J, Achan J, Clark T, Plenty A, Charlebois E, Kamya M, Young SL, Gandhi M, Havlir D, Cohan D, Aweeka F. PMID: 24038035; PMCID: PMC3933454.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    269. Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):578-84. Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, Huang Y, Clark T, Ades V, Natureeba P, Luwedde FA, Achan J, Kamya MR, Havlir DV, Cohan D, Prevention of Malaria and HIV disease in Tororo (PROMOTE) study. PMID: 24135775; PMCID: PMC3800282.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    270. Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda. AIDS Care. 2014; 26(3):360-6. Kim LH, Arinaitwe E, Nzarubara B, Kamya MR, Clark TD, Okong P, Charlebois ED, Havlir DV, Cohan D. PMID: 23909832.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    271. High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/μL under routine program conditions in Uganda. Clin Infect Dis. 2013 Nov; 57(9):1343-50. Namusobya J, Semitala FC, Amanyire G, Kabami J, Chamie G, Bogere J, Jain V, Clark TD, Charlebois E, Havlir DV, Kamya M, Geng EH. PMID: 23899683; PMCID: PMC3792723.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    272. Overcoming the human immunodeficiency virus obstacle course. JAMA Intern Med. 2013 Jul 22; 173(14):1344-5. Christopoulos KA, Havlir DV. PMID: 23778428.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    273. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis. 2013 Oct 15; 208(8):1212-20. Yukl SA, Shergill AK, Ho T, Killian M, Girling V, Epling L, Li P, Wong LK, Crouch P, Deeks SG, Havlir DV, McQuaid K, Sinclair E, Wong JK. PMID: 23852128; PMCID: PMC3778964.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    274. Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda. J Trop Pediatr. 2013 Dec; 59(6):441-6. Ades V, Mwesigwa J, Natureeba P, Clark TD, Plenty A, Charlebois E, Achan J, Kamya MR, Havlir DV, Cohan D, Ruel TD. PMID: 23764539; PMCID: PMC3842848.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    275. Household ventilation and tuberculosis transmission in Kampala, Uganda. Int J Tuberc Lung Dis. 2013 Jun; 17(6):764-70. Chamie G, Wandera B, Luetkemeyer A, Bogere J, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 23676159.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    276. Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS. 2013 Apr 24; 27(7):1159-65. Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, Katabira E, Lange J, Lima VD, Patterson T, Strathdee SA, Williams B, Montaner J. PMID: 23902921; PMCID: PMC4539010.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    277. Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clin Infect Dis. 2013 Aug; 57(4):586-93. Luetkemeyer AF, Rosenkranz SL, Lu D, Marzan F, Ive P, Hogg E, Swindells S, Benson CA, Grinsztejn B, Sanne IM, Havlir DV, Aweeka F, Adult AIDS Clinical Trials Group A5221 Study Team. PMID: 23592830; PMCID: PMC3719885.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    278. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy. Top Antivir Med. 2013 Apr-May; 21(2):62-74. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 23681961; PMCID: PMC6148869.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    279. WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):e101-3. Cohan D, Mwesigwa J, Natureeba P, Aliba Luwedde F, Ades V, Plenty A, Kakuru A, Achan J, Clark T, Osterbauer B, Kamya M, Havlir D. PMID: 23924639; PMCID: PMC3738916.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    280. Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda. AIDS. 2013 Feb 20; 27(4):627-34. Thirumurthy H, Chamie G, Jain V, Kabami J, Kwarisiima D, Clark TD, Geng E, Petersen ML, Charlebois ED, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 23169332; PMCID: PMC3809760.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    281. Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. Am J Trop Med Hyg. 2013 Apr; 88(4):744-6. Ikilezi G, Achan J, Kakuru A, Ruel T, Charlebois E, Clark TD, Rosenthal PJ, Havlir D, Kamya MR, Dorsey G. PMID: 23358639; PMCID: PMC3617863.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    282. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. Clin Infect Dis. 2013 Feb; 56(4):598-605. Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, Geng EH, Kwarisiima D, Wong JK, Abdel-Mohsen M, Sonawane N, Aweeka FT, Thirumurthy H, Petersen ML, Charlebois ED, Kamya MR, Havlir DV, SEARCH Collaboration. PMID: 23243180; PMCID: PMC3552523.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    283. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med. 2012 Nov 29; 367(22):2110-8. Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, Charlebois E, Aweeka F, Dorsey G, Rosenthal PJ, Havlir D, Kamya MR. PMID: 23190222; PMCID: PMC3664297.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    284. PR Interval and sudden cardiac death in patients with HIV infection. J Infect Dis. 2013 Jan 01; 207(1):199-200. Tseng ZH, Moyers B, Secemsky EA, Havlir DV, Hsue PY. PMID: 23186784; PMCID: PMC3523799.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    285. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2012 Nov 13; 26(17):2121-33. Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. PMID: 22695302; PMCID: PMC3819503.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    286. Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers. J Acquir Immune Defic Syndr. 2012 Nov 01; 61(3):310-6. Huang L, Parikh S, Rosenthal PJ, Lizak P, Marzan F, Dorsey G, Havlir D, Aweeka FT. PMID: 22918158; PMCID: PMC3511816.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    287. The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting. Clin Infect Dis. 2012 Dec; 55(12):1690-7. Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos KA, Deeks SG, Gandhi M, Havlir DV. PMID: 22955429; PMCID: PMC3501330.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    288. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012; 7(8):e43400. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Petersen ML, Thirumurthy H, Kamya MR, Havlir DV, Charlebois ED, SEARCH Collaboration. PMID: 22916256; PMCID: PMC3423366.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    289. Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy. PLoS One. 2012; 7(8):e41934. Young S, Murray K, Mwesigwa J, Natureeba P, Osterbauer B, Achan J, Arinaitwe E, Clark T, Ades V, Plenty A, Charlebois E, Ruel T, Kamya M, Havlir D, Cohan D. PMID: 22879899; PMCID: PMC3413694.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    290. The beginning of the end of AIDS? N Engl J Med. 2012 Aug 23; 367(8):685-7. Havlir D, Beyrer C. PMID: 22809362.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    291. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2012 Jun-Jul; 20(2):48-60. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 22710907; PMCID: PMC6148866.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    292. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012 May 22; 59(21):1891-6. Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, Havlir DV, Hsue PY. PMID: 22595409; PMCID: PMC3356565.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    293. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis. 2012 May; 54 Suppl 4:S245-9. Jordan MR, Bennett DE, Wainberg MA, Havlir D, Hammer S, Yang C, Morris L, Peeters M, Wensing AM, Parkin N, Nachega JB, Phillips A, De Luca A, Geng E, Calmy A, Raizes E, Sandstrom P, Archibald CP, Perriëns J, McClure CM, Hong SY, McMahon JH, Dedes N, Sutherland D, Bertagnolio S. PMID: 22544182; PMCID: PMC3338313.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    294. Social, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected men. PLoS One. 2012; 7(4):e35207. Riley ED, Neilands TB, Moore K, Cohen J, Bangsberg DR, Havlir D. PMID: 22558128; PMCID: PMC3338834.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    295. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis. 2012 Apr; 54(7):1001-9. Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, Rosenthal PJ, Dorsey G, Achan J, Akello C, Kamya MR, Wong JK. PMID: 22308272; PMCID: PMC3297647.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    296. HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc. 2012; 15(2):17396. Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV. PMID: 22905358; PMCID: PMC3499795.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    297. The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. Future Virol. 2012; 7(7):699-708. Kamya MR, Byakika-Kibwika P, Gasasira AF, Havlir D, Rosenthal PJ, Dorsey G, Achan J. PMID: 23293660; PMCID: PMC3535690.
      View in: PubMed   Mentions: 7  
    298. Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. AIDS. 2011 Nov 28; 25(18):2269-78. Haubrich RH, Riddler SA, Ribaudo H, Direnzo G, Klingman KL, Garren KW, Butcher DL, Rooney JF, Havlir DV, Mellors JW, AIDS Clinical Trials Group (ACTG) A5160 and A5142 Study Teams. PMID: 21941167; PMCID: PMC3572727.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    299. Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. J Acquir Immune Defic Syndr. 2011 Nov 01; 58(3):e96-9. Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG. PMID: 22005002; PMCID: PMC4120944.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    300. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011 Oct 20; 365(16):1482-91. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I, AIDS Clinical Trials Group Study A5221. PMID: 22010914; PMCID: PMC3327101.
      View in: PubMed   Mentions: 272     Fields:    Translation:HumansCells
    301. The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation. Clin Infect Dis. 2011 Nov; 53(10):1008-14. Geng EH, Kahn JS, Chang OC, Hare CB, Christopoulos KA, Jones D, Petersen ML, Deeks SG, Havlir DV, Gandhi M. PMID: 21960715; PMCID: PMC3193829.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    302. Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda. J Trop Pediatr. 2012 Jun; 58(3):194-9. Kay J, Wanzira H, Sandison T, Kakuru A, Bigira V, Kamya M, Homsy J, Tappero JW, Havlir D, Dorsey G, Ruel T. PMID: 21930666; PMCID: PMC3530275.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    303. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL. J Infect Dis. 2011 Sep 15; 204(6):884-92. Nanteza MW, Mayanja-Kizza H, Charlebois E, Srikantiah P, Lin R, Mupere E, Mugyenyi P, Boom WH, Mugerwa RD, Havlir DV, Whalen CC. PMID: 21849285; PMCID: PMC3156928.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    304. Tuberculosis drug development: ensuring people living with HIV are not left behind. Am J Respir Crit Care Med. 2011 Nov 15; 184(10):1107-13. Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV. PMID: 21868507; PMCID: PMC3361323.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    305. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis. 2011 Sep; 53(6):592-9. Ruel TD, Zanoni BC, Ssewanyana I, Cao H, Havlir DV, Kamya M, Achan J, Charlebois ED, Feeney ME. PMID: 21840929; PMCID: PMC3160805.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    306. Mortality among antiretroviral-eligible patients in an urban public clinic. J Acquir Immune Defic Syndr. 2011 Aug 01; 57(4):297-300. Dowdy DW, Geng EH, Christopoulos KA, Kahn JS, Hare CB, Wlodarczyk D, Havlir DV. PMID: 21602697; PMCID: PMC3159809.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    307. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11; 365(6):493-505. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team. PMID: 21767103; PMCID: PMC3200068.
      View in: PubMed   Mentions: 3441     Fields:    Translation:HumansCellsPHPublic Health
    308. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2011 May-Jun; 19(2):58-68. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 21868823; PMCID: PMC6148948.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    309. Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. J Virol Methods. 2011 Aug; 175(2):261-5. Yukl SA, Li P, Fujimoto K, Lampiris H, Lu CM, Hare CB, Deeks SG, Liegler T, Pandori M, Havlir DV, Wong JK. PMID: 21536073; PMCID: PMC3827908.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    310. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis. 2011 Apr 15; 52(8):1046-9. Charlebois ED, Das M, Porco TC, Havlir DV. PMID: 21460322; PMCID: PMC3070031.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    311. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. J Infect Dis. 2011 Apr 01; 203(7):992-1001. Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH. PMID: 21402550; PMCID: PMC3068037.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    312. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):44-50. Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK, Achan J. PMID: 21099693; PMCID: PMC3078046.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    313. Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2010 Nov; 55(3):330-5. Charlebois ED, Ruel TD, Gasasira AF, Achan J, Kateera F, Akello C, Cao H, Dorsey G, Rosenthal PJ, Ssewanyana I, Kamya MR, Havlir DV. PMID: 20592617; PMCID: PMC3025136.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    314. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2010 Oct 23; 24(16):2451-60. Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Günthard HF, Fischer M, Wong JK, Havlir DV. PMID: 20827162; PMCID: PMC2997807.
      View in: PubMed   Mentions: 142     Fields:    Translation:HumansCells
    315. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis. 2010 Nov 15; 202(10):1553-61. Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, Duan L, Choi AL, Girling V, Ho T, Li P, Fujimoto K, Lampiris H, Hare CB, Pandori M, Haase AT, Günthard HF, Fischer M, Shergill AK, McQuaid K, Havlir DV, Wong JK. PMID: 20939732; PMCID: PMC2997806.
      View in: PubMed   Mentions: 175     Fields:    Translation:HumansCellsCTClinical Trials
    316. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis. 2010 Oct; 14(10):1295-302. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 20843421; PMCID: PMC3033769.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    317. Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. J Virol Methods. 2010 Dec; 170(1-2):115-20. Li P, Ruel T, Fujimoto K, Hatano H, Yukl S, Eller LA, Liegler T, Kamya M, Gassasira A, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK. PMID: 20863855; PMCID: PMC3280821.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    318. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J Infect Dis. 2010 Sep 01; 202(5):705-16. Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B, AIDS Clinical Trials Group 5197 Study Team. PMID: 20662716; PMCID: PMC2916952.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsPHPublic Health
    319. "A bird in the hand...": a commentary on the test and treat approach for HIV. Arch Intern Med. 2010 Aug 09; 170(15):1354-6. Charlebois ED, Havlir DV. PMID: 20696961.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    320. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. Clin Infect Dis. 2010 Aug 01; 51(3):359-62. Chamie G, Charlebois ED, Srikantiah P, Walusimbi-Nanteza M, Mugerwa RD, Mayanja H, Okwera A, Whalen CC, Havlir DV. PMID: 20569064; PMCID: PMC2919368.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    321. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS. 2010 Jul 31; 24(12):1945-52. Bebell LM, Pilcher CD, Dorsey G, Havlir D, Kamya MR, Busch MP, Dunn Williams J, Nugent CT, Bentsen C, Rosenthal PJ, Charlebois ED. PMID: 20543656; PMCID: PMC2909782.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    322. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J. 2010 Jun 23; 9:177. Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, Ruel T, Kateera F, Meya DN, Havlir D, Rosenthal PJ, Dorsey G. PMID: 20573194; PMCID: PMC2903607.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    323. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS. 2010 May 15; 24(8):1163-70. Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK. PMID: 20425886; PMCID: PMC2880483.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    324. Tuberculosis as part of the natural history of HIV infection in developing countries. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S245-54. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV. PMID: 20397955; PMCID: PMC3032796.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    325. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010 Apr-May; 18(2):57-65. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 20516525; PMCID: PMC3032798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    326. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010 Apr 20; 74(16):1260-6. Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ, A5170 Study Team. PMID: 20237308; PMCID: PMC2860482.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCTClinical Trials
    327. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. PLoS One. 2010 Feb 22; 5(2):e9138. Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, Whalen CC, Boom WH, Uganda-Case Western Research Collaboration. PMID: 20179751; PMCID: PMC2825253.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    328. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J. 2009 Nov 14; 8:254. Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, Achan J, Havlir D, Rosenthal PJ, Dorsey G, Clark TD, Cohan D. PMID: 19912657; PMCID: PMC2781026.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsPHPublic Health
    329. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. J Acquir Immune Defic Syndr. 2009 Aug 01; 51(4):424-9. German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT. PMID: 19506482.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    330. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009 Jun 01; 23(9):1109-18. Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW, Mellors JW, Havlir DV, AIDS Clinical Trials Group (ACTG) A5142 Study Team. PMID: 19417580; PMCID: PMC2739977.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCellsCTClinical Trials
    331. Paradigm shift to address drug resistant tuberculosis in people living with HIV needed, and needed now. Trop Med Int Health. 2009 Apr; 14(4):376-8. Getahun H, Havlir D, Granich R, Reid A, Jaramillo E, Nunn P. PMID: 19302631.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    332. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2009 Apr-May; 17(2):57-67. Currier JS, Havlir DV. PMID: 19401608.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    333. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clin Immunol. 2009 Jun; 131(3):410-4. Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong JK, Cao H, Havlir D, Charlebois ED. PMID: 19303366; PMCID: PMC3032795.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    334. Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis. 2009 Mar 15; 48(6):725-32. Davis JL, Huang L, Kovacs JA, Masur H, Murray P, Havlir DV, Worodria WO, Charlebois ED, Srikantiah P, Cattamanchi A, Huber C, Shea YR, Chow Y, Fischer SH. PMID: 19207077; PMCID: PMC2657807.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    335. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. PMID: 19268337; PMCID: PMC4474533.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    336. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. AIDS Res Hum Retroviruses. 2009 Jan; 25(1):65-71. Ssewanyana I, Baker CA, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H. PMID: 19182922; PMCID: PMC2858297.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    337. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. J Acquir Immune Defic Syndr. 2008 Dec 01; 49(4):458-60. Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV. PMID: 19011423; PMCID: PMC4752197.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    338. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings. Int J Tuberc Lung Dis. 2008 Dec; 12(12):1370-5. Scano F, Vitoria M, Burman W, Harries AD, Gilks CF, Havlir D. PMID: 19017444.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    339. Confronting TB/HIV in the era of increasing anti-TB drug resistance. J Int AIDS Soc. 2008 Nov 06; 11:6. Chakaya J, Getahun H, Granich R, Havlir D. PMID: 19014421; PMCID: PMC2588552.
      View in: PubMed   Mentions: 4     Fields:    
    340. Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis. 2008 Aug 01; 47(3):421-4. Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV. PMID: 18558886; PMCID: PMC2586907.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    341. HIV integrase inhibitors--out of the pipeline and into the clinic. N Engl J Med. 2008 Jul 24; 359(4):416-8. Havlir DV. PMID: 18650518.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    342. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008 Jul 23; 300(4):423-30. Havlir DV, Getahun H, Sanne I, Nunn P. PMID: 18647985.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansPHPublic Health
    343. HIV RNA suppression among HIV-infected Ugandan children with measles. J Acquir Immune Defic Syndr. 2008 Jun 01; 48(2):225-7. Ruel TD, Achan J, Gasasira AF, Charlebois ED, Mehbratu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV. PMID: 18520684; PMCID: PMC3040680.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    344. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med. 2008 May 15; 358(20):2095-106. Riddler SA, Haubrich R, DiRienzo AG, Peeples L, Powderly WG, Klingman KL, Garren KW, George T, Rooney JF, Brizz B, Lalloo UG, Murphy RL, Swindells S, Havlir D, Mellors JW, AIDS Clinical Trials Group Study A5142 Team. PMID: 18480202; PMCID: PMC3885902.
      View in: PubMed   Mentions: 227     Fields:    Translation:HumansCellsCTClinical Trials
    345. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy. Top HIV Med. 2008 Apr-May; 16(1):23-30. Currier JS, Havlir DV. PMID: 18441380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    346. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis. 2008 Apr 01; 46(7):985-91. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G. PMID: 18444813.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    347. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 01; 197(3):411-9. Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. PMID: 18248304.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    348. HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. J Acquir Immune Defic Syndr. 2007 Dec 15; 46(5):624-30. Bebell LM, Gasasira A, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey G. PMID: 18043317.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    349. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007 Dec 15; 45(12):1633-9. Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM. PMID: 18190326.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    350. Profile of T cell immune responses in HIV-infected children from Uganda. J Infect Dis. 2007 Dec 01; 196(11):1667-70. Ssewanyana I, Elrefaei M, Dorsey G, Ruel T, Jones NG, Gasasira A, Kamya M, Nakiwala J, Achan J, Charlebois E, Havlir D, Cao H. PMID: 18008251.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    351. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS. 2007 Oct 01; 21(15):2059-66. Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. PMID: 17885296.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    352. Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda. AIDS. 2007 Sep 12; 21(14):1972-4. Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV. PMID: 17721107; PMCID: PMC4752198.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    353. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis. 2007 Aug 15; 196 Suppl 1:S46-51. Blanc FX, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy JF. PMID: 17624825.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    354. High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response. HIV Clin Trials. 2007 Jul-Aug; 8(4):193-204. Podzamczer D, King MS, Klein CE, Flexner C, Katlama C, Havlir DV, Letendre SL, Eron JJ, Brun SC, Bernstein B. PMID: 17720659.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    355. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. J Infect Dis. 2007 May 15; 195(10):1426-36. Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM, AIDS Clinical Trials Group 5170 Study Team. PMID: 17436222.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    356. Complications of HIV disease and therapy. Top HIV Med. 2007 Apr-May; 15(2):40-7. Currier JS, Havlir DV. PMID: 17485786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    357. Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clin Infect Dis. 2007 Mar 15; 44(6):889-91. German P, Greenhouse B, Coates C, Dorsey G, Rosenthal PJ, Charlebois E, Lindegardh N, Havlir D, Aweeka FT. PMID: 17304470.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    358. Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis. 2007 Feb; 11(2):168-74. Srikantiah P, Lin R, Walusimbi M, Okwera A, Luzze H, Whalen CC, Boom WH, Havlir DV, Charlebois ED. PMID: 17263287; PMCID: PMC2846511.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    359. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007 Apr 01; 175(7):737-42. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. PMID: 17218620; PMCID: PMC1899289.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    360. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. J Infect Dis. 2006 Nov 01; 194(9):1309-18. Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW, ACTG A5086 Study Team. PMID: 17041858.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    361. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol. 2006 Aug; 44(8):3021-4. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED. PMID: 16891532; PMCID: PMC1594619.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    362. Intensive care of patients with HIV infection. N Engl J Med. 2006 Jul 13; 355(2):173-81. Huang L, Quartin A, Jones D, Havlir DV. PMID: 16837681.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    363. Antiretroviral therapy and TB. Trop Doct. 2006 Apr; 36(2):73-9. Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV. PMID: 16611437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    364. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2006 Mar-Apr; 14(1):27-35. Havlir DV, Currier JS. PMID: 16641525.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    365. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Jan 01; 41(1):31-6. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. PMID: 16340470; PMCID: PMC4050666.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    366. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis. 2006 Jan 01; 193(1):9-15. Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. PMID: 16323126.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    367. Patents versus patients? Antiretroviral therapy in India. N Engl J Med. 2005 Aug 25; 353(8):749-51. Havlir DV, Hammer SM. PMID: 16120852.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    368. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother. 2005 Jul; 49(7):2983-5. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. PMID: 15980379; PMCID: PMC1168637.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimals
    369. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 01; 191(9):1410-8. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. PMID: 15809898.
      View in: PubMed   Mentions: 168     Fields:    Translation:HumansCells
    370. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2005 Mar-Apr; 13(1):16-23. Currier JS, Havlir DV. PMID: 15849369.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    371. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. J Infect Dis. 2005 Apr 01; 191(7):1164-8. Havlir DV, Koelsch KK, Strain MC, Margot N, Lu B, Ignacio CC, Miller MD, Wong JK, Gilead 903 Study Team. PMID: 15747253.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    372. Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics. J Infect Dis. 2005 Jan 15; 191(2):147-9. Srikantiah P, Charlebois E, Havlir DV. PMID: 15609222.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    373. The case for earlier treatment of HIV infection. Clin Infect Dis. 2004 Dec 01; 39(11):1699-704. Holmberg SD, Palella FJ, Lichtenstein KA, Havlir DV. PMID: 15578373.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    374. Atazanavir: new option for treatment of HIV infection. Clin Infect Dis. 2004 Jun 01; 38(11):1599-604. Havlir DV, O'Marro SD. PMID: 15156449.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    375. Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA. Top HIV Med. 2004 Mar-Apr; 12(1):31-45. Currier JS, Havlir DV. PMID: 15111728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    376. Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. AIDS. 2003 Nov 07; 17(16):2345-9. Gulick RM, Meibohm A, Havlir D, Eron JJ, Mosley A, Chodakewitz JA, Isaacs R, Gonzalez C, McMahon D, Richman DD, Robertson M, Mellors JW. PMID: 14571186.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    377. Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol. 2003 Oct; 77(20):11212-9. Havlir DV, Strain MC, Clerici M, Ignacio C, Trabattoni D, Ferrante P, Wong JK. PMID: 14512569; PMCID: PMC224988.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCellsCTClinical Trials
    378. Strategic approaches to antiretroviral treatment. Top HIV Med. 2003 Jul-Aug; 11(4):145-9. Havlir DV. PMID: 12876333.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    379. Responding to organ failure in HIV-infected patients. N Engl J Med. 2003 Jun 05; 348(23):2279-81. Roland ME, Havlir DV. PMID: 12788990.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    380. Complications of HIV infection and antiretroviral therapy. Top HIV Med. 2003 May-Jun; 11(3):86-91. Havlir DV, Currier JS. PMID: 12837967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    381. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4819-24. Strain MC, Günthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, Macaranas TR, Lam RY, Daly OA, Fischer M, Opravil M, Levine H, Bacheler L, Spina CA, Richman DD, Wong JK. PMID: 12684537; PMCID: PMC153639.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    382. Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity. Antimicrob Agents Chemother. 2002 Dec; 46(12):3877-82. Riddler SA, Havlir D, Squires KE, Kerr B, Lewis RH, Yeh K, Wynne LH, Zhong L, Peng Y, Deutsch P, Saah A. PMID: 12435691; PMCID: PMC132738.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    383. Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia. Antimicrob Agents Chemother. 2002 Dec; 46(12):3907-16. Shulman N, Zolopa A, Havlir D, Hsu A, Renz C, Boller S, Jiang P, Rode R, Gallant J, Race E, Kempf DJ, Sun E. PMID: 12435695; PMCID: PMC132776.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    384. Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med. 2002 Sep; 23(3):665-74. Jones D, Havlir DV. PMID: 12371002.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    385. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31(1):20-6. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. PMID: 12352146.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    386. The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society. AIDS. 2002 Jul 05; 16(10):7-9. Havlir D, Vella S, Hammer S. PMID: 12146462.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    387. A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):699-704. Pollard RB, Tierney C, Havlir D, Tebas P, Fox L, Smeaton L, Richman D, Friedland GH. PMID: 12167276.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    388. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002 Apr; 8(4):379-85. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. PMID: 11927944.
      View in: PubMed   Mentions: 548     Fields:    Translation:HumansCells
    389. To stop or not to stop: that is the question, but what is the answer? AIDS. 2002 Mar 29; 16(5):787-9. Hogg RS, Havlir D, Miller V, Montaner JS. PMID: 11964536.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    390. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS. 2002 Jan 25; 16(2):161-70. Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA. PMID: 11807299.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    391. Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):4-6. Havlir DV. PMID: 11782542; PMCID: PMC117502.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    392. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J Virol. 2002 Jan; 76(1):185-94. Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, Fu TM, Emini EA, Shiver JW. PMID: 11739684; PMCID: PMC135696.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    393. Adding two new drug classes improves outcome in salvage therapy. AIDS Clin Care. 2001 Oct; 13(10):99. Havlir D. PMID: 11590928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    394. Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS. 2001 Jul 27; 15(11):1379-88. Havlir DV, Gilbert PB, Bennett K, Collier AC, Hirsch MS, Tebas P, Adams EM, Wheat LJ, Goodwin D, Schnittman S, Holohan MK, Richman DD, ACTG 5025 Study Group. PMID: 11504959.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    395. Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA. 2001 Jul 11; 286(2):171-9. Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK. PMID: 11448280.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansCells
    396. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy. Virology. 2001 Jun 05; 284(2):250-8. Frost SD, Günthard HF, Wong JK, Havlir D, Richman DD, Leigh Brown AJ. PMID: 11384224.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    397. Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy. J Infect Dis. 2001 May 15; 183(10):1455-65. Huang W, De Gruttola V, Fischl M, Hammer S, Richman D, Havlir D, Gulick R, Squires K, Mellors J. PMID: 11319681.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    398. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J Infect Dis. 2001 May 01; 183(9):1318-27. Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, Gamagami R, Emini E, Haase A, Richman DD, Wong JK. PMID: 11294662.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    399. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis. 2001 Feb 15; 183(4):555-62. Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, Krieger J, Pryor J, Havlir D, Wong JK, Schooley RT, Richman D, Corey L, Haase AT. PMID: 11170980.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    400. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol. 2001 Jan; 39(1):298-303. Havlir DV, Torriani FJ, Schrier RD, Huang JY, Lederman MM, Chervenak KA, Boom WH. PMID: 11136787; PMCID: PMC87718.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    401. Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients. AIDS. 2000 Dec 22; 14(18):2869-76. Zhou XJ, Havlir DV, Richman DD, Acosta EP, Hirsch M, Collier AC, Tebas P, Sommadossi JP, AIDS Clinical Trials Study 343 Investigators. PMID: 11153668.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans